Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
MA19 - Genomic Markers of IO Response
- 15:15 - 16:45
- 9/25/2018
- Location: Room 201 BD
- Type: Mini Oral Abstract Session
- Track: Immunooncology
-
+
MA19.01 - Efficacy and Genomic Correlates of Response to Anti-PD1/PD-L1 Blockade in Non-Small Cell Lung Cancers Harboring Targetable Oncogenes
15:15 - 15:20 | Presenter: Natalie Vokes | Author(s): Elizabeth Jimenez Alguilar, Anika Adeni, Renato Umeton, Lynette M Sholl, Hira Rizvi, Matthew D. Hellmann, Mark M. Awad, Eliezer M. Van Allen
- Abstract
Loading... -
+
MA19.03 - Discussant - MA 19.01
15:20 - 15:35 | Presenter: Jonathan W. Goldman
- Abstract
No abstract available for this presentation
-
+
MA19.04 - The Clinical Implication of Frameshift Indel Mutation Burden in Non-Small Cell Lung Cancer (NSCLC)
15:35 - 15:40 | Presenter: Young Kwang Chae | Author(s): Wungki Park, Diana Saravia, Vaia Florou, Sangmin Chang, Si Wang, Lauren Chiec, Ashkon Alexander Rahbari, Nisha Mohindra, Victoria Villaflor, Lee Chun Park, Gilberto de Lima Lopes
- Abstract
Loading... -
+
MA19.05 - Difference of Tumor Mutational Burden Is Associated with Distinct Immune Microenviroment in the T Cell-Inflamed Lung Adenocarcinoma
15:40 - 15:45 | Presenter: Takahiro Karasaki | Author(s): Kentaro Kitano, Kazuhiro Nagayama, Jun-ichi Nitadori, Masaaki Sato, Masaki Anraku, Kazuhiro Kakimi, Jun Nakajima
- Abstract
Loading... -
+
MA19.06 - Blood Based Biomarkers: RNA, KRAS and PD-L1 Strongly Matching with Tissue and Showing Correlation with Clinical Responses In NSCLC Patient’s
15:45 - 15:50 | Presenter: Luis E Raez | Author(s): Joshua Usher, Cheryl Habaue, Kathleen Danenberg, Brian Hunis, Yolanda Jaimes, Shahrooz Rabizadeh, Aurelio Castrellon, Peter Danenberg
- Abstract
Loading... -
+
MA19.07 - Discussant - MA 19.04, MA 19.05, MA 19.06
15:50 - 16:05 | Presenter: Claudia Poleri
- Abstract
No abstract available for this presentation
-
+
MA19.08 - Detection of Primary Immunotherapy Resistance to PD-1 Checkpoint Inhibitors (PD1CI) in 2nd Line NSCLC
16:05 - 16:10 | Presenter: Joachim G.J.V. Aerts | Author(s): Egbert F Smit, Mirte Muller, Anna-Larissa Nadia Niemeijer, Carlos Oliveira, Heinrich Roder, Joanna Roder
- Abstract
Loading... -
+
MA19.09 - Concurrent Mutations in STK11 and KEAP1 is Associated with Resistance to PD-(L)1 Blockade in Patients with NSCLC Despite High TMB
16:10 - 16:15 | Presenter: Kathryn C Arbour | Author(s): Ronglai Shen, Andrew Plodkowski, Hira Rizvi, Ai Ni, Niamh Long, Darragh Halpenny, Francisco Sanchez-Vega, Charles M. Rudin, Gregory J Riely, Matthew D. Hellmann
- Abstract
Loading... -
+
MA19.10 - Impact of STK11/LKB1 Genomic Alterations on Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC
16:15 - 16:20 | Presenter: Ferdinandos Skoulidis | Author(s): Yasir Y Elamin, Vincent K Lam, Jianjun Zhang, Jeff Lewis, Waree Rinsurongkawong, Jack Lee, Jack A Roth, Stephen Swisher, Vassiliki A Papadimitrakopoulou, John V Heymach
- Abstract
Loading... -
+
MA19.11 - Discussant - MA 19.08, MA 19.09, MA 19.10
16:20 - 16:35 | Presenter: Lynette M Sholl
- Abstract
No abstract available for this presentation
-
+
MA19.12 - Q&A
16:35 - 16:45
- Abstract
No abstract available for this presentation
-
+
MA20 - Implementation of Lung Cancer Screening
- 15:15 - 16:45
- 9/25/2018
- Location: Room 206 F
- Type: Mini Oral Abstract Session
- Track: Screening and Early Detection
-
+
MA20.01 - Lung Cancer Screenee Selection by USPSTF versus PLCOm2012 Criteria – Preliminary ILST Findings
15:15 - 15:20 | Presenter: Martin Tammemägi | Author(s): Renelle L Myers, Mamta Ruparel, Niloofar Taghizadeh, Sukhinder Atkar-Khattra, Jennifer Dickson, Samantha Quaife, Angshu Bhowmik, Paul Burrowes, Paul Maceachern, Eric Bedard, John Yee, John Mayo, Jing Liu, Kwun M Fong, Alain Tremblay, Sam M Janes, Stephen Lam
- Abstract
Loading... -
+
MA20.02 - “Reduced” HUNT Lung Cancer Model for Predicting Lung Cancer in the Prospective Danish Lung Cancer Screening Study - Comparison with the NLST.
15:20 - 15:25 | Presenter: Oluf Dimitri Røe | Author(s): Maria Markaki, Ioannis Tsmardinos, Vincenzo Lagani, Jesper Holst Pedersen, Zaigham Saghir, Haseem Ashraf
- Abstract
Loading... -
+
MA20.03 - Surprising Implications of Proposed Risk-Thresholds for Selecting US Ever-Smokers into CT Lung-Cancer Screening
15:25 - 15:30 | Presenter: Hormuzd Katki | Author(s): Christine Berg, Anil Chaturvedi, Rebecca Landy, Hilary Robbins, Li C Cheung
- Abstract
Loading... -
+
MA20.04 - Discussant - MA 20.01, MA 20.02, MA 20.03
15:30 - 15:45 | Presenter: Amanda Tufman
- Abstract
No abstract available for this presentation
-
+
MA20.05 - Who Gets Screened for Lung Cancer? A Simple Adjustment to Current Guidelines to Reduce Racial Disparities
15:45 - 15:50 | Presenter: Melinda Aldrich | Author(s): Sarah Mercaldo, Kim L. Sandler, William J Blot, Eric Grogan, Jeffrey Blume
- Abstract
Loading... -
+
MA20.06 - Lung Cancer Screening Pilot for People at High Risk: Early Results on Cancer Detection and Staging
15:50 - 15:55 | Presenter: Martin Tammemägi | Author(s): Gail Elizabeth Darling, Heidi Schmidt, Monica Yu, Marianne Luettschwager, Bogdan Pylypenko, Tanvi Patel, Veronica Rivera, Katharine Pearson, Katie Larson
- Abstract
Loading... -
+
MA20.07 - Lung Cancer Screening for Limited-Resource Patients: Preliminary Findings from a Low-dose CT Pilot Program
15:55 - 16:00 | Presenter: Lesley Watson | Author(s): Megan May Cotter, Robert A. Smith, Katherine Sharpe
- Abstract
Loading... -
+
MA20.08 - Discussant - MA 20.05, MA 20.06, MA 20.07
16:00 - 16:15 | Presenter: Annette Maree McWilliams
- Abstract
No abstract available for this presentation
-
+
MA20.09 - Improved Lung Cancer and Mortality Prediction Accuracy Using Survival Models Based on Semi-Automatic CT Image Measurements
16:15 - 16:20 | Presenter: Anton Schreuder | Author(s): Colin Jacobs, Nikolas Lessmann, Ernst Scholten, Ivana Isgum, Mathias Prokop, Cornelia Schaefer-Prokop, Bram Van Ginneken
- Abstract
Loading... -
+
MA20.10 - Lung Cancer Prediction Using Deep Learning Software: Validation on Independent Multi-Centre Data
16:20 - 16:25 | Presenter: Peter Van Ooijen | Author(s): Heiko Peschl, Daiwei Han, Matthijs Oudkerk, Monique Dorrius, Mieneke Rook, Rozemarijn Vliegenthart, Claus Peter Heussel, Nadja Batora, Hans-Ulrich Kauczor, Carlos Da Silva, Oyunbileg Von Stackelberg, Roman Rubtsov, Mark Wielputz, Sarim Ather, Maria Tsakok, Carlos Arteta, Lyndsey Pickup, Samia Hussain, William Hickes, Petr Novotny, Catarina Santos, Emily Fay, Jerome Declerck, Vaclav Potesil, Timor Kadir, Fergus V Gleeson
- Abstract
Loading... -
+
MA20.12 - Discussant - MA 20.09, MA 20.10
16:25 - 16:40 | Presenter: Heidi Schmidt
- Abstract
No abstract available for this presentation
-
+
MA20.12a - Q&A
16:40 - 16:45
- Abstract
No abstract available for this presentation
-
+
MA21 - Molecular Subtyping, CBL3, and Non Coding RNA
- 15:15 - 16:45
- 9/25/2018
- Location: Room 205 BD
- Type: Mini Oral Abstract Session
- Track: Biology
-
+
MA21.01 - Cbl Mutations (mt) as Important Mediators of Oncogenic RTK Signaling in NSCLC
15:15 - 15:20 | Presenter: Rebecca Feldman | Author(s): Ari M. Vanderwalde, Stephen V Liu, Martin Frederik Dietrich, Shirish Gadgeel, Wolfgang M. Korn, Jorge Nieva, Alexander Spira, Edward S Kim
- Abstract
Loading... -
+
MA21.02 - Identification of an E2 Ubiquitin Conjugase CDC34 That Competes With E3 Ligase c-Cbl to Stabilize EGFR and Promotes Lung Carcinogenesis
15:20 - 15:25 | Presenter: Guangbiao Zhou | Author(s): Xin-Chun Zhao, Yun-Chao Huang
- Abstract
Loading... -
+
MA21.03 - Heterogeneity in MET Copy Number and Intratumoural Subsets in Pleomorphic Lung Carcinoma: Implications for MET Directed Therapy in NSCLC
15:25 - 15:30 | Presenter: Adam Januszewski | Author(s): Yu Zhi Zhang, Wei-Chin Chang, Ute Laggner, Alex Bowman, Toyin Adefila-Ideozu, William OC Cookson, Miriam F Moffatt, Andrew G Nicholson, Anne Bowcock, Sanjay Popat
- Abstract
Loading... -
+
MA21.04 - Discussant - MA 21.01, MA 21.02, MA 21.03
15:30 - 15:45 | Presenter: Ravi Salgia
- Abstract
No abstract available for this presentation
-
+
MA21.05 - Comprehensive Genomic Characterization and Prognostic Nomogram Developed by 295-Gene Panel Targeted Sequencing
15:45 - 15:50 | Presenter: Bin Zhang | Author(s): Lianmin Zhang, Tengfei Zhang, Dongsheng Yue, Chenguang Li, Zhenfa Zhang, Jun-Yi Ye, Hongming Wang, Shannon Chuai, Changli Wang
- Abstract
Loading... -
+
MA21.06 - Proteins Associated with Survival Differ Depending on Molecular Subtypes, and Mutational- and Smoking-Status In NSCLC Biopsies
15:50 - 15:55 | Presenter: Ann Rita Halvorsen | Author(s): Mads Haugland Haugen, Åsa Kristina Øjlert, Steinar Solberg, Lars Jørgensen, Gunhild M Mælandsmo, Odd Terje Brustugun, Åslaug Helland
- Abstract
Loading... -
+
MA21.07 - A Nation-Wide Population-Based Mapping of Targetable Alterations in Smoking-Independent Lung Cancer
15:55 - 16:00 | Presenter: Maria Planck | Author(s): Annette Salomonsson, Annika Patthey, Christel Reuterswärd, Mats Jönsson, Johan Botling, Hans Brunnström, Aziz Hussein, Nastaran Monsef, Cristian Ortiz-Villalon, Bengt Bergman, Luigi De Petris, Kristina Lamberg, Anders Vikström, Gunnar Wagenius, Annelie Behndig, Eva Brandén, Mikael Johansson, Hirsh Koyi, Johan Staaf
- Abstract
Loading... -
+
MA21.08 - Discussant - MA 21.05, MA 21.06, MA 21.07
16:00 - 16:15 | Presenter: Siddhartha Devarakonda
- Abstract
No abstract available for this presentation
-
+
MA21.09 - Differential Gene Expression in Tumor and Normal Tissue Reveals New Insights in the Biology of Non-Small Cell Lung Carcinoma.
16:15 - 16:20 | Presenter: Alan Spatz | Author(s): Vladimir Lazar, Eitan Rubin, Katherine D. Lach, Hangjun Wang, Andreas Papadakis, Roy Moscona, Patricia Jimenez, Goulnar Kasymjanova, Victor Cohen, Jason S Agulnik, Leon van Kempen
- Abstract
Loading... -
+
MA21.10 - Large-Scale Discovery of Novel Human Oncofetal Transcripts in Lung
16:20 - 16:25 | Presenter: Brenda C. Minatel | Author(s): Victor D Martinez, Adam P Sage, Erin A Marshall, Tomas Tokar, Daiana D. Becker-Santos, Wendy P. Robinson, Igor Jurisica, Wan Lam
- Abstract
Loading... -
+
MA21.11 - Epigenomic Mapping of Cell-Free DNA in Patients with Non-Small Cell Lung Cancer
16:25 - 16:30 | Presenter: Christine M Bestvina | Author(s): Jordan Karpus, Xiao-long Cui, Claire Oosterbaan, Brian Won, Chuan He, Jyoti Patel
- Abstract
Loading... -
+
MA21.12 - Discussant - MA 21.09, MA 21.10, MA 21.11
16:30 - 16:45 | Presenter: Geoffrey Liu
- Abstract
No abstract available for this presentation
-
+
MA22 - New Therapeutics, Pathology, and Brain Metastases for Small Cell and Neuroendocrine Tumour
- 15:15 - 16:45
- 9/25/2018
- Location: Room 206 BD
- Type: Mini Oral Abstract Session
- Track: Small Cell Lung Cancer/NET
-
+
MA22.01 - PARP Inhibitor Radiosensitization of Small Cell Lung Cancer Differs by PARP Trapping Potency
15:15 - 15:20 | Presenter: Benjamin H Lok | Author(s): James H Laird, Jennifer Ma, Elisa De Stanchina, John Poirier, Charles M. Rudin
- Abstract
Loading... -
+
MA22.02 - Activation of MAPK Suppresses Neuroendocrine Transcription Factors and Causes Transdifferentiation of Small Cell Lung Cancer
15:20 - 15:25 | Presenter: Yusuke Inoue | Author(s): William Lockwood
- Abstract
Loading... -
+
MA22.03 - SCLC Circulating Tumour Cell Derived Explants: The Clinical Characteristics of Patients Whose Samples Generate CDX
15:25 - 15:30 | Presenter: Alexander John Vickers | Author(s): Louise Carter, Melanie Galvin, Mathew Carter, Lynsey Franklin, Karen Morris, Jacqueline Pierce, Kristopher Frese, Fiona Blackhall, Caroline Dive
- Abstract
Loading... -
+
MA22.04 - Discussant - MA 22.01, MA 22.02, MA 22.03
15:30 - 15:45 | Presenter: Céline Mascaux
- Abstract
No abstract available for this presentation
-
+
MA22.05 - Impact of Tumor Spread Through Air Spaces (STAS) in Lung Neuroendocrine Tumors (NETs)
15:45 - 15:50 | Presenter: Katsura Emoto | Author(s): Rania Gaber Aly, Takashi Eguchi, Kyuichi Kadota, Natasha Rekhtman, Kay See Tan, Prasad S. Adusumilli, William D Travis
- Abstract
Loading... -
+
MA22.06 - Preinvasive Multifocal Neuroendocrine Lesions with Primary Typical Carcinoid Lung Tumors: A Negative Prognostic Factor?
15:50 - 15:55 | Presenter: Niccolo Daddi | Author(s): Valentina Tassi, Elisa Scarnecchia, Frances Allison, Jacopo Vannucci, Rosanna Capozzi, Valeria Liparulo, Kazuhiro Yasufuku, Marc De Perrot, Andrew Pierre, Özgür Mete, Renato Colella, Stefano Ascani, Piero Ferolla, Gail Elizabeth Darling, Shaf Keshavjee, Francesco Puma, Thomas Kenneth Waddell
- Abstract
Loading... -
+
MA22.07 - Prognostic Value of Distant Organ-Specific Metastases in Newly Diagnosed Lung Neuroendocrine Tumors: A Population-Based Study
15:55 - 16:00 | Presenter: Min Fan | Author(s): Junmiao Wen, Jiayan Chen, Di Liu, Xinyan Xu, Junhua Zhang, Yu Gu, Lv Huang
- Abstract
Loading... -
+
MA22.08 - Discussant - MA 22.05, MA 22.06, MA 22.07
16:00 - 16:15 | Presenter: Giuseppe Pelosi
- Abstract
No abstract available for this presentation
-
+
MA22.09 - Should Stereotactic Radiosurgery be Considered for Salvage of Intracranial Recurrence in Small Cell Lung Cancer?
16:15 - 16:20 | Presenter: Brooklyn Mazure | Author(s): Neil Guest, Ariel Letcher, Sunita Ghosh, Zsolt Gabos, Karen P Chu, Brock Debenham, Tirath Nijjar, Diane Severin, Rufus Scrimger, Wilson Roa, Don Yee, Alysa Fairchild
- Abstract
Loading... -
+
MA22.10 - Prevalence and Risk Factors of Brain Metastases in Limited Stage Small Cell Lung Cancer Immediately Before Prophylactic Cranial Irradiation
16:20 - 16:25 | Presenter: Zhengfei Zhu | Author(s): Xiao Chu, Xi Yang
- Abstract
Loading... -
+
MA22.11 - Risk of Hippocampal Metastases in Small Cell Lung Cancer: Implications for Hippocampal Sparing Cranial Irradiation
16:25 - 16:30 | Presenter: Rachel Effeney | Author(s): Lekshmi Nair, Michelle Murphy, Craig Hukins, Margot Lehman, G Tao Mai
- Abstract
Loading... -
+
MA22.12 - Discussant - MA 22.09, MA 22.10, MA 22.11
16:30 - 16:45 | Presenter: Houda Bahig
- Abstract
No abstract available for this presentation
-
+
MS20 - Innovative and Evolving Strategies in Diagnosis and Management of Stage I NSCLC
- 15:15 - 16:45
- 9/25/2018
- Location: Room 202 BD
- Type: Mini Symposium
- Track: Treatment of Early Stage/Localized Disease
-
+
MS20.01 - Robotic and Innovative Surgery
15:15 - 15:30 | Presenter: Waël C. Hanna
- Abstract
No abstract available for this presentation
-
+
MS20.02 - The Future of Stereotactic Ablative Radiotherapy (SABR)
15:30 - 15:45 | Presenter: Billy W Loo
- Abstract
No abstract available for this presentation
-
+
MS20.03 - Immunotherapy and Surgery: Neoadjuvant or Adjuvant? Is It Safe?
15:45 - 16:00 | Presenter: Jamie E Chaft
- Abstract
No abstract available for this presentation
-
+
MS20.04 - Prediction of Clinical Outcome in NSCLC Using Integrative Genomics: Implications for Adjuvant Chemotherapy
16:00 - 16:15 | Presenter: Phillippe Broet
- Abstract
No abstract available for this presentation
-
+
MS20.05 - Beyond Surgery - Support of the Surgical Patient
16:15 - 16:30 | Presenter: Kate Kuhns
- Abstract
No abstract available for this presentation
-
+
MS20.06 - Less Is More: Segmentectomy in the Management of Early Stage NSCLC
16:30 - 16:45 | Presenter: Shun-ichi Watanabe
- Abstract
No abstract available for this presentation
-
+
MS21 - Giants in Thoracic Oncology
- 15:15 - 17:00
- 9/25/2018
- Location: Room 105
- Type: Mini Symposium
- Track:
-
+
MS21.01 - Surgery and its Evolution
15:15 - 15:25 | Presenter: Paul Emile Van Schil
- Abstract
No abstract available for this presentation
-
+
MS21.02 - Chemotherapy through the 21st Century
15:25 - 15:35 | Presenter: David H Johnson
- Abstract
No abstract available for this presentation
-
+
MS21.03 - Revolution in Radiation
15:35 - 15:45 | Presenter: Ben Slotman
- Abstract
No abstract available for this presentation
-
+
MS21.04 - Targeted Therapy - The Second Revolution
15:45 - 15:55 | Presenter: Frances A Shepherd
- Abstract
No abstract available for this presentation
-
+
MS21.05 - Quality of Life - Are we Paying Enough Attention?
15:55 - 16:05 | Presenter: Richard J Gralla
- Abstract
No abstract available for this presentation
-
+
MS21.06 - Immunotherapy - Sequence or Combination?
16:05 - 16:15 | Presenter: Roy S. Herbst
- Abstract
No abstract available for this presentation
-
+
MS21.07 - The Growing Role of Biomarkers in Treatment Selection: “The Tissue is the Issue”
16:15 - 16:25 | Presenter: Fred R. Hirsch
- Abstract
No abstract available for this presentation
-
+
MS21.08 - Where will we be in 10 years?
16:25 - 16:35 | Presenter: Paul A. Bunn, Jr.
- Abstract
No abstract available for this presentation
-
+
MS21.09 - Discussion
16:35 - 17:00
- Abstract
No abstract available for this presentation
-
+
OA12 - Novel Therapies in MET, RET and BRAF
- 15:15 - 16:45
- 9/25/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA12.01 - Phase II Data for the MET Inhibitor Tepotinib in Patients with Advanced NSCLC and MET Exon 14-Skipping Mutations
15:15 - 15:25 | Presenter: Enriqueta Felip | Author(s): Hiroshi Sakai, Jyoti Patel, Leora Horn, Remi Veillon, Frank Griesinger, Rolf Bruns, Jürgen Scheele, Paul K. Paik
- Abstract
Loading... -
+
OA12.02 - Updated Antitumor Activity of Crizotinib in Patients with MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer
15:25 - 15:35 | Presenter: Alexander Drilon | Author(s): Jeffrey W. Clark, Jared Weiss, Sai-Hong Ignatius Ou, Ross Camidge, Ben J Solomon, Gregory A. Otterson, Liza Villaruz, Gregory J Riely, Rebecca Heist, Geoffrey I. Shapiro, Danielle A. Murphy, Sherry C. Wang, Tiziana Usari, Sherry Li, Keith D. Wilner, Paul K. Paik
- Abstract
Loading... -
+
OA12.03 - Activity of Crizotinib in MET or ROS1 Positive (+) NSCLC: Results of the AcSé Trial.
15:35 - 15:45 | Presenter: Denis Moro-Sibilot | Author(s): Nathalie Cozic, Maurice Pérol, Josiane Otto, Julien Mazieres, Pierre-Jean Souquet, Rastislav Bahleda, Marie Wislez, Sophie De Guibert, Bertrand Mennecier, Christos Chouaid, Renaud Sabatier, Suzanna Bota, Radj Gervais, Véronique Verriele, Véronique Haddad, Gilbert Ferretti, Frédérique Nowak, Céline Mahier - Ait Oukhatar, Gilles Vassal
- Abstract
Loading... -
+
OA12.04 - Discussant - OA 12.01, OA 12.02, OA 12.03
15:45 - 16:00 | Presenter: Mark M. Awad
- Abstract
No abstract available for this presentation
-
+
OA12.05 - Vemurafenib in Patients Harboring V600 and Non V600 BRAF Mutations: Final Results of the NSCLC Cohort from the AcSé Trial.
16:00 - 16:10 | Presenter: Julien Mazieres | Author(s): Laure Montané, Fabrice Barlesi, Bruno Coudert, Pierre Jean Souquet, Josiane Otto, Radj Gervais, Denis Moro-Sibilot, Isabelle Monnet, Etienne Brain, Olivier Huillard, Gilles Quéré, Didier Debieuvre, Elisabeth Fabre, Marion Jaffro, Samia Collot, Gilbert Ferretti, Céline Tiffon, Céline Mahier - Ait Oukhatar, Jean-Yves Blay
- Abstract
Loading... -
+
OA12.06 - Mutational Landscape of BRAF V600E Positive Lung Cancer Patients Following BRAF Directed Therapy Failure
16:10 - 16:20 | Presenter: Anastasios Dimou | Author(s): Terry L. Ng, Anna Chalmers, Michael E. Devitt, Anh Le, Vikas Malhotra, Vasu Malhotra, Richard Hall, Thereasa Rich, Wallace Akerley, Jun Zhang, Dara L. Aisner, Ross Camidge, Robert C. Doebele
- Abstract
Loading... -
+
OA12.07 - Clinical Activity of LOXO-292, a Highly Selective RET Inhibitor, in Patients with RET Fusion+ Non-Small Cell Lung Cancer
16:20 - 16:30 | Presenter: Geoffrey R. Oxnard | Author(s): Vivek Subbiah, Keunchil Park, Todd M. Bauer, Lori J Wirth, Vamsidhar Velcheti, Manisha Shah, Benjamin Besse, Valentina Boni, Karen L. Reckamp, Herbert H Loong, Lyudmila Bazhenova, Ben J Solomon, Daniel S.W. Tan, Jyoti Patel, Melissa L. Johnson, Anas Gazzah, Tony S. Mok, Steve Smith, Brian Tuch, Kevin Ebata, Edward Y Zhu, Michele M Nguyen, Xin Huang, Scott Cruickshank, S Michael Rothenberg, Alexander Drilon
- Abstract
Loading... -
+
OA12.08 - Discussant - OA 12.05, OA 12.06, OA 12.07
16:30 - 16:45 | Presenter: Thomas Newsom-Davis
- Abstract
No abstract available for this presentation
-
+
P2.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.01-01 - The Impact of Anlotinib on Brain Metastases of NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)
16:45 - 18:00 | Presenter: Wenhua Liang | Author(s): Yi Zhao, Yalei Zhang, Xi Han, Xinyun Yang, Jianxing He, Kai Li, Baohui Han, - On Behalf Of The Alter0303 Investigators
- Abstract
Loading... -
+
P2.01-02 - Osimertinib for EGFR-Positive Advanced NSCLC with Brain Metastases: Preliminary Analysis of an Open-Label, Two-Arm, Phase 2 Study
16:45 - 18:00 | Presenter: Nir Peled | Author(s): Ofer Rotem, Anna Belilovski Rozenblum, Hovav Nechushtan, Lilach Chen, Elizabeth Dudnik, Alona Zer, Shlomit Yust-Katz, Ilan Shelef, Laila C. Roisman, Edna Inbar
- Abstract
Loading... -
+
P2.01-03 - Quality of Life Outcomes for FDA-Approved Agents in Advanced Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Hamzeh Albaba | Author(s): Andrea Bezjak, Natasha B Leighl
- Abstract
Loading... -
+
P2.01-04 - Reducing Time to Molecular Diagnosis for Advanced NSCLC in the Context of a Reference Testing Center
16:45 - 18:00 | Presenter: Alla'a Ali | Author(s): Gurdip Singh Tamber, Sophie Camilleri-Broet, Victor Cohen, Jonathan David Spicer, Hangjun Wang, George Chong, Majed Munazzit, Caroline Rousseau, Warren Sateren, Myriam Fernandez, Goulnar Kasymjanova, Scott Owen, Alan Spatz, Leon Van Kempen, Jason S Agulnik
- Abstract
Loading... -
+
P2.01-05 - Adenocarcinoma of the Lung: The Woman’s Cancer?
16:45 - 18:00 | Presenter: Noor Asaad Alsaadoun | Author(s): Amanda Gibson, Adrijana D’silva, Anifat A. Elegbede, Michelle L Dean, Emeka K Enwere, Shannon Mary Otsuka, Roxana A. Tudor, Gwyn Bebb
- Abstract
Loading... -
+
P2.01-06 - HSP72 Expression Associates with Survival in EGFR Mutated NSCLC
16:45 - 18:00 | Presenter: Idoroenyi Amanam | Author(s): Paul Frankel, Stephanie Mach, Emily Dickinson, Li Zheng, Binghui Shen, Karen L. Reckamp
- Abstract
Loading... -
+
P2.01-07 - Safety and Efficacy of LATTICE Radiotherapy in Voluminous Non-Small Cell Lung Cancer: A Retrospective Study of 10 Patients Over 7 Year Period
16:45 - 18:00 | Presenter: James Melotek | Author(s): Beatriz E Amendola, Naipy C Perez, Ian Qureshi, Marco A Amendola, Xiaodong Wu
- Abstract
Loading... -
+
P2.01-08 - Conversion Surgery for Locally Advanced Lung Adenocarcinoma Harboring Driver Gene Mutation After TKI Followed by Cytotoxic Agent
16:45 - 18:00 | Presenter: Masaya Aoki | Author(s): Tadashi Umehara, Go Kamimura, Takuya Tokunaga, Toshiyuki Nagata, Aya Harada Takeda, Naoya Yokomakura, Kota Kariatsumari, masakazu Yanagi, Masami Sato
- Abstract
Loading... -
+
P2.01-09 - Targetable Genomic Alterations in KRAS Mutant Lung Adenocarcinoma by Targeted Next Generation Sequencing
16:45 - 18:00 | Presenter: Edurne Arriola | Author(s): Sergi Clave, Max Hardy-Werbin, Alvaro Taus, Pedro Rocha, Imane Chaib, Enric Carcereny, Marta Salido, Alba Dalmases, Beatriz Bellosillo
- Abstract
Loading... -
+
P2.01-10 - Prognostic Impact of Longitudinal Monitoring of Radiomic Features in Patients with Advanced Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: So Hyeon Bak | Author(s): Hyunjin Park, Insuk Sohn, Ho Yun Lee, Seung Hak Lee, Myung-Ju Ahn
- Abstract
Loading... -
+
P2.01-100 - Different Genetic Mutations Enriched in Circulating Tumor DNA Predict Different Metastatic Sites in Lung Adenocarcinoma Patients
16:45 - 18:00 | Presenter: Liyun Miao | Author(s): Jinjin Wang, Jun Zhao, Xinghao Ai, Gen Lin, Rongrong Chen, Xuefeng Xia
- Abstract
Loading... -
+
P2.01-101 - Dynamic Monitoring of Gene Alterations with ctDNA by NGS for EGFR Mutated Lung Adenocarcinoma Treated with Gefitinib in BENEFIT Study (CTONG 1405)
16:45 - 18:00 | Presenter: Jie Wang | Author(s): Jian-Chun Duan, Shuhang Wang, Zhi-Jie Wang, Hua Bai, Jun Zhao, Hongjun Gao, Ying Cheng
- Abstract
Loading... -
+
P2.01-102 - Comprehensive Next-Generation Sequencing Guided Targeted Therapies Improve Clinical Outcomes of Lung Cancer Patients
16:45 - 18:00 | Presenter: Zhaoxia Wang | Author(s): Dongqin Zhu, Binbin Lu, Guojian Liu, Tianwei Xu
- Abstract
Loading... -
+
P2.01-103 - Neutrophil-to-Lymphocyte Ratio as a Predictor of Immunotherapy Treatment Outcomes in Advanced Non-Small Lung Cancer
16:45 - 18:00 | Presenter: Xiao Wang | Author(s): Wei Fu, Chen Hu, Jarushka Naidoo, Josephine Feliciano
- Abstract
Loading... -
+
P2.01-104 - Plasma T-Cell-Derived Circulating DNA in Advanced NSCLC is Not Correlated with TIL but has a Potential of Prognostic Value
16:45 - 18:00 | Presenter: Chanida Vinayanuwattikun | Author(s): Bowon Weerasubpong, Poonchavist Chantranuwatana, Virote Sriuranpong
- Abstract
Loading... -
+
P2.01-105 - Tumor Treating Fields Plus Standard of Care for Non-Small Cell Lung Cancer Following Platinum Failure: Phase 3 LUNAR Study
16:45 - 18:00 | Presenter: Uri Weinberg | Author(s): Ori Farber, Moshe Giladi, Zeev Bomzon, Eilon D. Kirson
- Abstract
Loading... -
+
P2.01-106 - A Comparative Analysis of Genomic Alterations by Tumor Tissue and Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Go-un Woo | Author(s): Se Hyun Kim, Koung Jin Suh, Yu Jung Kim, Jin-Haeng Chung, Byung-Chul Lee, Nak-Jung Kwon, Jeong-Sun Seo, Jong Seok Lee
- Abstract
Loading... -
+
P2.01-107 - Analysis of Mutation Detection by ctDNA on the Basis of Metastatic Sites in Lung Adenocarcinoma Patients
16:45 - 18:00 | Presenter: Renhua Guo | Author(s): Huamin Xu, Jie Xia Zhang, Xinghao Ai, Li Liu, Jun Zhao, Xiaorong Dong, Liyun Miao, Rongrong Chen, Xuefeng Xia
- Abstract
Loading... -
+
P2.01-108 - Temporal Heterogeneity of Resistant Mutations in Sequential ALK TKI Treated Lung Cancer Revealed by NGS-Based Liquid Biopsy
16:45 - 18:00 | Presenter: Yu Yang | Author(s): Yan Ding, Xue Wu, Yang W. Shao
- Abstract
Loading... -
+
P2.01-109 - Treatment Duration—A More Reasonable Definition to Evaluate the Efficacy of Crizotinib in ALK Positive Advanced NSCLC
16:45 - 18:00 | Presenter: Guangjian Yang | Author(s): Di Ma, Junling Li, Puyuan Xing, Xuezhi Hao, Haiyan Xu, Yan Wang
- Abstract
Loading... -
+
P2.01-11 - Characteristics of Non-Small Cell Lung Cancer: Differences by Sex and Hormonal Status in a Hispanic Population
16:45 - 18:00 | Presenter: Feliciano Barron | Author(s): Vianey Rodriguez-Lara, Laura-Alejandra Ramírez-Tirado, Diana Flores, Zyanya Lucia Zatarain-Barrón, Oscar Arrieta
- Abstract
Loading... -
+
P2.01-110 - Unique Genomic Profile Revealed by Malignant Pleural Effusion
16:45 - 18:00 | Presenter: Zhihua Guo | Author(s): Weiqiang Yin, Dongyong Yang, Zhanhong Xie, Huifang Shi, Wei Du, Lijun Peng, Jianxing He
- Abstract
Loading... -
+
P2.01-111 - Clinical Features and Prognosis of Eighty-Five Patients with Primary Pulmonary Lymphoepithelioma-Like Carcinoma
16:45 - 18:00 | Presenter: Qin Yin Yin | Author(s): Guo Ying Gao, Cheng Zhi Zhou, Yi Qian Liu, Xiao Hong Xie, Xin Qing Lin, Zheng Zhu, Zhan Hong Xie, Jie Xia Zhang, Ou Yang Ming, Rong Chang Chen, Shi Yue Li
- Abstract
Loading... -
+
P2.01-112 - Prognostic Value of Changes in Neutrophil-To-Lymphocyte Ratio in Patients with Lung Cancer Treated with Nivolumab
16:45 - 18:00 | Presenter: Takashi Yokoi | Author(s): Eisuke Shibata, Ryo Takahashi, Koji Mikami, Shingo Kanemura, Yuichi Koda, Yoshiki Negi, Eriko Fujimoto, Yumiko Akano, Akio Tada, Toshiyuki Minami, Kozo Kuribayashi, Takashi Kijima
- Abstract
Loading... -
+
P2.01-113 - Prognostic Roles of Neoadjuvant and Adjuvant Chemotherapy for Treating Patients with Operable Stage III-N2 Non-Small Cell Lung Cancer (NSCLC)
16:45 - 18:00 | Presenter: Luo-Sheng Yong | Author(s): Shuenn-Wen Kuo, Pei-Wen Yang, Pei-Ming Huang, Mong-Wei Lin, Ke-Cheng Chen, Jang-Ming Lee
- Abstract
Loading... -
+
P2.01-114 - The Correlation Among PD-L1 Expression, TMB and Lung Immune Prognostic Index in Chinese Patients with Advanced Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Pei Yuan | Author(s): Yuan Li, Lili Jiang, Yueping Liu, Wei Liu, Jianming Ying
- Abstract
Loading... -
+
P2.01-115 - Evaluation of EGFR T790M of Cell Free Circulating DNA in Plasma by Droplet Digital PCR for Progressive Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Zhihong Zhang
- Abstract
Loading... -
+
P2.01-116 - The Potential of Assessing Blood Tumor Mutation Burden (bTMB) Using a Large Panel
16:45 - 18:00 | Presenter: Kai Zhang | Author(s): Yong Tang, Xinhua Xu, Weiping Tao, Zhiguo Rao, Fanghong Wu, Shixing An, Jun Liu, Jinsong Yang, Ting Hou, Lu Zhang, Yu Zhang, Li Liu, Sheng Zhang
- Abstract
Loading... -
+
P2.01-117 - Concurrent Gene Alterations in Treatment-Naïve EGFR-Mutant Advanced Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Xuefeng Xia | Author(s): Jun Zhao, Min Zhang, Jiexia Zhang, Likun Chen, Renhua Guo, Gen Lin, Tiejun Yin, Hong Shi, Wenxian Wang, Chunwei Xu, Rongrong Chen
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.01-119 - Phase III Randomized Trial of Palonosetron and Dexamethasone with Aprepitant to Prevent Full Dose Single-Day Cisplatin-Based CINV in Lung Cancer
16:45 - 18:00 | Presenter: Yongchang Zhang | Author(s): Nong Yang, Fang Wu
- Abstract
Loading... -
+
P2.01-12 - Ramucirumab+Docetaxel Usage Following Rapid Disease Progression in Real World Advanced Non-Small Cell Lung Cancer Patients
16:45 - 18:00 | Presenter: Marta Batus | Author(s): Cliff Molife, Jeffrey Melson Clarke, Victoria Jennifer Stefaniak, Katherine B Winfree, Zhanglin L Cui, Yimei Han, Mahesh K Tawney, Philip Bonomi
- Abstract
Loading... -
+
P2.01-120 - First Study to Evaluate the Efficacy of SB Oral Solution to Prevent Neutropenia and FN Induced by Platinum-Based Chemotherapy in Lung Cancer
16:45 - 18:00 | Presenter: Yongchang Zhang | Author(s): Fanxu Zeng, Ting Li, Li Liu, Nong Yang
- Abstract
Loading... -
+
P2.01-121 - Genomic Profiling of Pulmonary Lymphoepithelioma-Like Carcinoma
16:45 - 18:00 | Presenter: Chengzhi Zhou | Author(s): Zhanhong Xie, Yinyin Qin, Xiaohong Xie, Xinqing Lin, Jiexia Zhang, Ming Ouyang, Bing Li, Jing Liu, Suiyi Mai, Lu Zhang
- Abstract
Loading... -
+
P2.01-122 - Individual Precision Surgery for Locally Advanced Non-small Cell Lung Cancer Based on Molecular Staging and Typing : The Chinese Experience.
16:45 - 18:00 | Presenter: Qinghua Zhou
- Abstract
Loading... -
+
P2.01-123 - Translational Medicine of Lung Cancer Metastasis: From Bench to Bedside
16:45 - 18:00 | Presenter: Qinghua Zhou
- Abstract
Loading... -
+
P2.01-124 - SIB-IMRT in Symptomatic Brain Metastases for NSCLC: A Randomized Controlled Study of WBRT Comparing 25Gy and 30Gy
16:45 - 18:00 | Presenter: Jian Zhu | Author(s): Qinghui Dong, Wei Wang, Xingni Tang, Yinnan Meng, Feng-Ming Spring Kong, Haihua Yang
- Abstract
Loading... -
+
P2.01-125 - EGFR Mutations by NGS in Advanced Squamous Cell Lung Cancer
16:45 - 18:00 | Presenter: Govind Babu K | Author(s): Deepak Koppaka, Ramprasad Vl
- Abstract
Loading... -
+
P2.01-126 - MicroRNA-330-3p Modulates Tumor Vascular Normalization After Hypofractionated Radiotherapy by Targeting p-STAT3/ HIF-1 Alpha Pathway
16:45 - 18:00 | Presenter: Xiaorong Dong | Author(s): Xiong Chun Jin, Chunhua Wei, Hui Lu, Fan Tong
- Abstract
Loading... -
+
P2.01-127 - Efficacy of Endostar Combined with Whole Brain Radiotherapy in Patients with NSCLC Brain Metastases
16:45 - 18:00 | Presenter: Xiaorong Dong | Author(s): Lingjuan Chen, Chunhua Wei, Ruiguang Zhang, Hui Lu, Pengcheng Li, Gang Wu
- Abstract
Loading... -
+
P2.01-128 - Low Positivity Rate in T790M Detection with ctDNA in NSCLC and Post EGFR-TKI Progression – Timing or Sensitivity?
16:45 - 18:00 | Presenter: Carlos Gil Ferreira | Author(s): Mariano Zalis, Mauro Zukin, Clarissa Mathias, Carolina Kawamura Haddad, Eldsamira Mascarenhas, Luiz H. Araujo, Tatiane Caldas Montella, Marcelo Graziano Custodio, Bruna Silva, Carolina Bustamante, Giuliana Montenegro, Angelita Muras, Marcelo Reis
- Abstract
Loading... -
+
P2.01-129 - Potential Impact of KRAS Molecular Profiling of Non-Squamous Non-Small Cell Lung Cancer (NSCLC).
16:45 - 18:00 | Presenter: Nagla Abdel Karim | Author(s): Joshua Pathrose, Hassana Fathallah, Ihab El Desouki, Ashley Perry, Sandra Starnes, John Morris
- Abstract
Loading... -
+
P2.01-13 - Number, Rather Than Location of Metastases, Dictates Outcome in Stage IV, M1b, Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Amanda Jane Williams Gibson | Author(s): Haocheng Li, Adrijana D'Silva, Roxana A. Tudor, Anifat A. Elegbede, Shannon Mary Otsuka, Gwyn Bebb, Winson Y Cheung
- Abstract
Loading... -
+
P2.01-130 - Detection of Actionable Mutation Status in Advanced Non-Small Cell Lung Cancer by Next-Generation Sequencing of Circulating Tumor DNA
16:45 - 18:00 | Presenter: Xia Song | Author(s): YanLi Yang, wei Guo
- Abstract
Loading... -
+
P2.01-131 - Apatinib as an Alternative for Advanced Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Jiexia Zhang | Author(s): Zhuolin Wu, Hui Pan, Meifeng Ye, lixuan Chen, Weiping Qian
- Abstract
Loading... -
+
P2.01-132 - Comparison Molecular Profiles in NSCLC by Using Different NGS Platforms and
Different Variant Frequency Cutoff16:45 - 18:00 | Presenter: Thanyanan Reungwetwattana | Author(s): Somthawin Lukrak, Pimpin Incharoen, Supoj Detarkom, Sarunporn Techasurungkul, Narumol Trachu, Nareenart Iemwimangsa, Pareena Janchompoo, Wasun Chantratita
- Abstract
Loading... -
+
P2.01-14 - Preferred and Achieved Goals of Patients with Metastatic Lung Cancer and Their Oncologists in End-of-Life Therapy
16:45 - 18:00 | Presenter: Annemarie Becker | Author(s): Adinda Mieras, Roeline Pasman, Bregje Onwuteaka-Philipsen
- Abstract
Loading... -
+
P2.01-15 - A Radiologist-Led Training Workshop for MR Based Normal Tissue and Tumour Delineation for Lung Cancer Radiotherapy.
16:45 - 18:00 | Presenter: Sean Brown | Author(s): Michael Dubec, Hannah Bainbridge, David Catharina Petrus Cobben, Ferry Lalezari, Fiona McDonald, Hamid Sheikh, Corine Van Es, Marcel Van Herk, Corinne Faivre-Finn
- Abstract
Loading... -
+
P2.01-16 - Dynamic ctDNA Monitoring Revealed Novel Resistance Mechanisms and Response Predictors of Osimertinib Treatment in East Asian NSCLC Patients
16:45 - 18:00 | Presenter: Jianhua Chang | Author(s): Zhihuang Hu, Dongmei Ji, Shannon Chuai, Weina Shen, Junning Cao, Jialei Wang, Xianghua Wu
- Abstract
Loading... -
+
P2.01-17 - MALAT1-Mir-101-SOX9 Feedback Loop Modulates the Chemo-Resistance of Lung Cancer Cell to DDP via Wnt Signaling Pathway
16:45 - 18:00 | Presenter: Wei Chen
- Abstract
Loading... -
+
P2.01-18 - Differential Molecular Mechanisms Associated with Dramatic and Gradual Progression in NSCLC Patients with Intrathoracic Dissemination
16:45 - 18:00 | Presenter: Ying Chen | Author(s): Bao Hua, Wei Li, Chao Zhang, Wen-Fang Tang, Ao Wang, Xue Wu, Jing-Hua Chen, Jian Su, Yang W. Shao, Yi-Long Wu, Wen-Zhao Zhong
- Abstract
Loading... -
+
P2.01-19 - Radiomics Features of Contrast Enhanced CT as Prognostic Factors in Resectable Adenocarcinoma of Lung
16:45 - 18:00 | Presenter: Jooae Choe | Author(s): Sang Min Lee, Joon Beom Seo, Se Hoon Choi
- Abstract
Loading... -
+
P2.01-20 - FLT-PET for Detection of Relapse Following Radiotherapy for Lung Cancer. Preliminary Results
16:45 - 18:00 | Presenter: Tine Nøhr Christensen | Author(s): Seppo W Langer, Klaus Richter Larsen, Gitte Fredberg Persson, Annemarie G Amtoft, Helle Hjorth Johannesen, Sune Høgild Keller, Andreas Kjaer, Barbara Malene Fischer
- Abstract
Loading... -
+
P2.01-21 - Antigen Cascade Triggering Correlates with Prolonged Survival in Advanced NSCLC Patients Undergone PD-1 Blockade with Nivolumab.
16:45 - 18:00 | Presenter: PIERPAOLO Correale | Author(s): Rocco Giannicola, Graziella D'Arrigo, Pierpaolo Pastina, Valerio Nardone, Cirino Botta, Vito Barbieri, Giovanni Tripepi, Marika Monoriti, Luigi Pirtoli, Rita Saladino, Antonia Falzea, Pierosandro Tagliaferri
- Abstract
Loading... -
+
P2.01-22 - Increased Incidence, Morbidity and Mortality Rates for Lung Cancer in Women in Brazil Between 2000 and 2014
16:45 - 18:00 | Presenter: Guilherme Jorge Costa | Author(s): Maria Júlia Gonçalves De Mello, Carlos Gil Ferreira, Anke Bergmann, Luiz Claudio Santos Thuler
- Abstract
Loading... -
+
P2.01-23 - Baseline Plasma Biomarkers Predict Long-Term Responses to ALK-TKIs in ALK+ Advanced Non-Small Cell Lung Cancer (NSCLC)
16:45 - 18:00 | Presenter: Mathilde Couetoux Du Tertre | Author(s): Maud Marques, Luisa Izzi, Lise Tremblay, Nicole Bouchard, Rasvan Diaconescu, Normand Blais, Cyrla Hoffert, Archana Srivastava, Suzan McNamara, Gerald Batist, Victor Cohen, Jason S Agulnik
- Abstract
Loading... -
+
P2.01-24 - MLPH Activates CDC42/PAK1 Signaling to Promote Epithelial–Mesenchymal Transition via TGF-β in Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Xiaorong Dong | Author(s): Chunhua Wei, Ling Peng, Fan Tong, Chunjin Xiong
- Abstract
Loading... -
+
P2.01-25 - MicroRNA-330-3p Promotes Brain Metastasis of Non-Small Cell Lung Cancer by Activating MAPK/MEK/ERK Signaling Through GRIA3
16:45 - 18:00 | Presenter: Xiaorong Dong | Author(s): Chunhua Wei, Qian Cai, Xican Gao, Fan Tong
- Abstract
Loading... -
+
P2.01-26 - Association of Base Excision Repair Gene Polymorphisms with Response to Chemotherapy of Advanced Non Small-Cell Lung Cancer
16:45 - 18:00 | Presenter: Xu Wang | Author(s): Jie Dong, Jiuwei Cui
- Abstract
Loading... -
+
P2.01-27 - MR, CT and Cone-Beam CT for Lymph Node Visualisation in Locally-Advanced Lung Cancer
16:45 - 18:00 | Presenter: Sean Brown | Author(s): Michael Dubec, Ahmed Salem, David Catharina Petrus Cobben, Marcel Van Herk, Corinne Faivre-Finn
- Abstract
Loading... -
+
P2.01-28 - Gender and Systemic Treatment Patterns: Impacts on the Overall Survival of Stage IV NSCLC 2010 – 2014 Diagnoses
16:45 - 18:00 | Presenter: Anifat A. Elegbede | Author(s): Haocheng Li, Adrijana D'Silva, Amanda Jane Williams Gibson, Roxana A. Tudor, Michelle Dean, Shannon Mary Otsuka, Gwyn Bebb
- Abstract
Loading... -
+
P2.01-29 - Economic Analysis of Osimertinib in Previously Untreated EGFR-Positive Advanced Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Doreen Anuli Ezeife | Author(s): Veronica Kirk, Peter Coyte, Nancy Nixon, Rebecca Hancock-Howard, Natasha B Leighl
- Abstract
Loading... -
+
P2.01-30 - Applicability of Lung-molGPA Index in Non-Small Cell Lung Cancer Patients with Different Gene Alterations and Brain Metastases
16:45 - 18:00 | Presenter: Yun Fan | Author(s): Kaiyan Chen, Yanjun Xu, Zhiyu Huang, Xiaoqing Yu, Haiyang Wang
- Abstract
Loading... -
+
P2.01-31 - Updated EGFR Mutation Frequency in 1,689 NSCLC Brazilian Patients – A National-Wide Study
16:45 - 18:00 | Presenter: Carlos Gil Ferreira | Author(s): Mariano Zalis, Mauro Zukin, Gilberto Castro Jr, Clarissa Mathias, Carolina Kawamura Haddad, Vladmir CC de Lima, Luiz H. Araujo, Clarissa Baldotto, Ana Caroline Zimmer Gelatti, Carolina Bustamante, Marcelo Graziano Custodio, Giuliana Montenegro, Alessandra Souza, Marcelo Reis
- Abstract
Loading... -
+
P2.01-32 - Economic Evaluation of Diagnostic Platforms for T790M Detection in Post EGFR-TKI NSCLC in Brazil
16:45 - 18:00 | Presenter: Carlos Gil Ferreira | Author(s): Marcelo Graziano Custodio, Giuliana Montenegro, Rosangela Caetano, Luciene Bonan
- Abstract
Loading... -
+
P2.01-33 - Open-Label, Biomarker-Directed Platform Study in NSCLC Patients Who Progressed on an Anti-PD-(L)1 Containing Therapy (HUDSON)
16:45 - 18:00 | Presenter: Patrick M Forde | Author(s): John V Heymach, Michael Thomas, Keunchil Park, Benjamin Besse, Mark M. Awad, Glenwood Goss, Naiyer A Rizvi, Helen J Ambrose, Philip John Jewsbury, Barbara Koetz, Si-Houy Lao-Sirieix, Peter G Mortimer, Sabina I Patel, Kris Sachsenmeier, Wolfram Brugger
- Abstract
Loading... -
+
P2.01-34 - Prognostic Value of Neutrophil to Lymphocyte Ratio for Metastatic NSCLC Patients Treated with Immunotherapy and Ramucirumab Plus Docetaxel.
16:45 - 18:00 | Presenter: Marta Batus | Author(s): Ibtihaj Fughhi, Philip Bonomi, Mary Jo Fidler, Sanjib Basu, Jeffrey Borgia
- Abstract
Loading... -
+
P2.01-35 - Predicting Risk of Chemotherapy-Induced Severe Neutropenia in Patients with Advanced Lung Cancer
16:45 - 18:00 | Presenter: Apar Kishor Ganti | Author(s): Xiaowen Cao, Chen Shen, Thomas E. Stinchcombe, Jeffrey Crawford, Herbert Pang, Xiaofei Wang
- Abstract
Loading... -
+
P2.01-36 - Real-World Treatment Patterns in Treatment-Naïve Advanced NSCLC Patients in North America: A Systematic Literature Review
16:45 - 18:00 | Presenter: Yong Yuan | Author(s): Aleksandra Gara, Nebibe Varol, Sarah Goring, Tina Li, Mariana Oviedo Ovando, Nadine Hertel, Beata Korytowsky
- Abstract
Loading... -
+
P2.01-37 - A Ph 1/2 Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) with Docetaxel in pts with Previously Treated NSCLC
16:45 - 18:00 | Presenter: David E Gerber | Author(s): Sawsan Rashdan, Jessica Williams, Penny Currykosky, Farjana Fattah, Jonathan Padro Arroyo, Rebecca Smith, Robert Holt, Rolf Brekken
- Abstract
Loading... -
+
P2.01-38 - Sarcopenia is Associated with Metastatic Burden and is a Negative Prognostic Factor in Metastatic Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Chad Glisch | Author(s): Kathleen Monahan, Dhiraj Baruah, Jonathan R Thompson, Ziyan Yin, Aniko Szabo, Jayshil Patel, Smitha P. Menon
- Abstract
Loading... -
+
P2.01-39 - Can Benefit or Futility in Treating Advanced Nsclc Be Determined Early Using the LCSS 3-Item Global Index (3-IGI) PRO?
16:45 - 18:00 | Presenter: Richard J Gralla | Author(s): Patricia J. Hollen, Richard Hall, Ryan Gentzler, Haiying Cheng, Balazs Halmos, Jeffrey Crawford, Jane Cerise, Martin Lesser
- Abstract
Loading... -
+
P2.01-40 - Prognostic Importance of Sarcopeni and Inflammatory Statements in Stage III Non Small Cell Lung Carcinoma
16:45 - 18:00 | Presenter: Serap Akyürek | Author(s): Esra Gümüştepe, Yakup Arslan, Emrah Özgür Gökay, Şaban Çakir GÖkÇe
- Abstract
Loading... -
+
P2.01-41 - The Role and Mechanism Of FBW7 Deficiency in Advanced Non-Small Cell Lung Cancer with Docetaxel Resistance
16:45 - 18:00 | Presenter: Qisen Guo | Author(s): Honglu Liang
- Abstract
Loading... -
+
P2.01-42 - Impact of Tobacco Smoking on Outcomes in Patients with Metastatic Non-Small Cell Lung Cancer in the Era of Targeted Therapy
16:45 - 18:00 | Presenter: Martin Gutierrez | Author(s): Antoinette Wozniak, Corey J Langer, Bruno Fang, Giselle Alexandra Suero-Abreu, Andrew D Norden, Keaton D Bedell, James Schaffer, Ann Collins, Eric V Schultz, Brian Stone, Viraj Narayanan, Stuart Lee Goldberg
- Abstract
Loading... -
+
P2.01-43 - ADSCaN: A Randomised Phase II Study of Accelerated, Dose Escalated, Sequential Chemo-Radiotherapy in Non-Small Cell Lung Cancer (NSCLC)
16:45 - 18:00 | Presenter: Matthew Hatton | Author(s): Claire Lawless, Corinne Faivre-Finn, David Landau, Kathleen Boyd, John D Fenwick, Jason Lester, Elaine McCartney, James Paul, Ann Shaw, Rita Simoes
- Abstract
Loading... -
+
P2.01-44 - Prognostic Value of TP53 Hot Exon Mutation in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
16:45 - 18:00 | Presenter: Yong He | Author(s): Renhua Guo, Yutao Liu, Fang Xu, Yubo Wang, Jin Cao, Qingchen Wu, Zhang-Han Han, Jun-Yi Ye, Lu Zhang, Xinru Mao, Zhe Zhang, Jing Liu, Yu Zhang
- Abstract
Loading... -
+
P2.01-45 - Mutational and Inflammatory Biomarkers for Lung Cancer Patients with Pleural Effusions
16:45 - 18:00 | Presenter: Balazs Hegedus | Author(s): Daniel Valdivia, Henry Paul Koziej, Elena Loscha, Paul Stockhammer, Till Plönes, Khaled Mardanzai, Mohamed Zaatar, Dirk Theegarten, Clemens Aigner
- Abstract
Loading... -
+
P2.01-46 - Investigating the Effects of Prior Malignancy on NSCLC Trial Eligibility
16:45 - 18:00 | Presenter: Michael Herman | Author(s): Natasha B Leighl, Frances A Shepherd, Geoffrey Liu, Penelope Bradbury
- Abstract
Loading... -
+
P2.01-47 - Clinical Outcome After Surgical Resection Of Clinical Single-station N2 Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Kwanyong Hyun | Author(s): Samina Park, Hyun Joo Lee, In Kyu Park, Chang Hyun Kang, Young Tae Kim
- Abstract
Loading... -
+
P2.01-48 - Predictive Factors in NSCLC Patients with Stage IIIB/IV Treated with First Line Platinum-Doublet Chemotherapy
16:45 - 18:00 | Presenter: Sofi Isaksson | Author(s): Christel Reuterswärd, Bassam Hazem, Håkan Griph, Jens Engleson, Kajsa Ericson Lindquist, Maria Planck, Johan Staaf
- Abstract
Loading... -
+
P2.01-49 - Comparision of Radiotheraphy Concurrent Weekly Treatment in Locally Advanced Unresectable Non Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Abdurrahman İsikdogan | Author(s): Nadiye Akdeniz, Muhammet Ali Kaplan, Zuhat Urakci, Mehmet Kucukoner, Ogur Karhan
- Abstract
Loading... -
+
P2.01-50 - Thromboembolism in ROS1 Rearranged Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Nick Pavlakis | Author(s): Malinda Itchins, Marliese Alexander, Thomas John, Steven Chuan-Hao Kao, Brett G.M Hughes, Adrian Lee, Sarah A Hayes, Rozelle Harvie, Viive M Howell, Stephen J Clarke, Michael Millward
- Abstract
Loading... -
+
P2.01-51 - Study of CD26/DPP4 Expression in a Large Series of Non-Small Cell Lung Cancer Patients
16:45 - 18:00 | Presenter: Sven Hillinger | Author(s): Jae-Hwi Jang, Martina Haberecker, Alessandra Curioni Fontecedro, Florian Janker, Ignacio Gil-Bazo, Ilseon Hwang, Kunyoung Kwon, Walter Weder, Alex Soltermann, Wolfgang Jungraithmayr
- Abstract
Loading... -
+
P2.01-52 - Identification of Leptomeningeal Metastasis-Specific Exosomal miRNA Signatures in Cerebrospinal Fluids of NSCLC Patients
16:45 - 18:00 | Presenter: Yang W. Shao | Author(s): Ben-Yuan Jiang, Yang-Si Li, Xue Wu, Bao Hua, Yan Ding, Jin -Ji Yang, Xu-Chao Zhang, Xue-Ning Yang, Wen-Zhao Zhong, Qing Zhou, Hai-Yan Tu, Cun Yi Gao, Shuyu Wu, Yi-Long Wu
- Abstract
Loading... -
+
P2.01-53 - Local Treatment for Oligoprogression/Oligometastases After Failure to Crizotinib for ALK-Rearranged Stage IV Lung Cancer
16:45 - 18:00 | Presenter: Tsz Yeung Kam | Author(s): Jacky Yu Chung Li, M.Y. Lim, Oscar S.H. Chan, K.C Cheung, Victor Lee
- Abstract
Loading... -
+
P2.01-54 - Predictive Factors for Thromboembolism in Advanced Lung Cancer Patients on Platinum Chemotherapy: A Prospective Study
16:45 - 18:00 | Presenter: Shruti Kate | Author(s): Amit Joshi, Kumar Prabhash, Vanita Noronha, Vijay Patil
- Abstract
Loading... -
+
P2.01-55 - Dual-Energy CT Scan to Evaluate Sarcopenia in Lung Cancer in Comparison with Conventional CT Scan
16:45 - 18:00 | Presenter: Eun Young Kim | Author(s): Joohwan Park, Yong Saing Kim, Hee Young Lee, Hee Kyung Ahn, Shin Myung Kang
- Abstract
Loading... -
+
P2.01-56 - Metastases in Residual PET Uptake of Lymph Nodes After Treatment: Added Value of CT Radiomic Approach for Prediction
16:45 - 18:00 | Presenter: Chu Hyun Kim | Author(s): Ho Yun Lee, Hong Kwan Kim, Joon Young Choi
- Abstract
Loading... -
+
P2.01-57 - Prognostic Implication of Clinical, Imaging, and Pathologic Parameters in N2(+) Stage IIIA Lung Cancer Patients
16:45 - 18:00 | Presenter: Yong Chan Ahn | Author(s): Hakyoung Kim, Jin Man Kim, Hongryull Pyo, Jae Myoung Noh, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Yong Soo Choi, Jhingook Kim, Jae Ill Zo, Young Mog Shim, Joungho Han, Seung Hyup Hyun, Joon Young Choi
- Abstract
Loading... -
+
P2.01-58 - Demographics, Clinical Characteristics and Treatment Sequencing in Stage III Unresectable NSCLC Patients: A Cancerlinq Cohort
16:45 - 18:00 | Presenter: Alyssa B Klein | Author(s): Iksha Herr, Sharon Maclachlan, Danielle Potter
- Abstract
Loading... -
+
P2.01-59 - The Cost of Lung Cancer in the County of Gävleborg – Sweden
16:45 - 18:00 | Presenter: Hirsh Koyi | Author(s): Johan Isaksson, Nikolaos Melas, Eva Brandén
- Abstract
Loading... -
+
P2.01-60 - Clinical Utility of Circulating Tumor Cell (CTC) Analysis Using Target Selector™ in Metastatic NSCLC Chemotherapy Patients
16:45 - 18:00 | Presenter: Lara Kujtan | Author(s): Cecile Rose T Vibat, Veena M. Singh, Kevin F Kennedy, Anuj Shrestha, Sheshadri Madhusudhana, Jacob Smeltzer, Ashiq Masood, Janakiraman Subramanian
- Abstract
Loading... -
+
P2.01-61 - Body Mass Index over Time is Associated with Overall Survival in Advanced NSCLC Patients Treated with Immunotherapy.
16:45 - 18:00 | Presenter: Stephanie Labomascus | Author(s): Ibtihaj Fughhi, Philip Bonomi, Andrew McDonald, Marta Batus, Mary Jo Fidler, Sanjib Basu, Jeffrey Borgia
- Abstract
Loading... -
+
P2.01-62 - Extracellular Vesicle-Based Egfr Genotyping in Bronchoalveolar Lavage Fluid from Non-Small Cell Lung Cancer Patients
16:45 - 18:00 | Presenter: Jong Sik Lee | Author(s): Jae Young Hur, In Ae Kim, Hee Joung Kim, Wan Seop Kim, Kye Young Lee
- Abstract
Loading... -
+
P2.01-63 - Are Heart Doses Associated with Survival in NSCLC Treated with Post-Operative Radiotherapy? A National Population-Based Study
16:45 - 18:00 | Presenter: Chia Ching Lee | Author(s): Gail Wan Ying Chua, Huili Zheng, Yu Yang Soon, Ling Li Foo, Anuradha Thiagarajan, Swee Peng Yap, Tian Rui Siow, Wee Loon Ng, Kevin Lee Min Chua, Connie Yip, Brendan Seng Hup Chia, Yan Yee Ng, Zubin Master, Poh Wee Tan, Yun Inn Tan, Yuh Fun Leong, Joan Faith Evacula Loria, Balamurugan Vellayappan, Wee Yao Koh, Cheng Nang Leong, Jeremy Chee Seong Tey, Ivan Weng Keong Tham, Kam Weng Fong
- Abstract
Loading... -
+
P2.01-64 - Prognostic Value of PET-CT after Induction Chemoradiotherapy and Curative Surgery in IIIA-N2 NSCLC: A Multi-Institutional Analysis
16:45 - 18:00 | Presenter: Jong Hoon Lee
- Abstract
Loading... -
+
P2.01-65 - Assessment of Individual and Combined of Five Serum Tumor Markers for Lung Cancer
16:45 - 18:00 | Presenter: Yuping Li | Author(s): Hanyan Xu, Junru Ye, Chengshui Chen
- Abstract
Loading... -
+
P2.01-66 - Comparison of EGFR Mutation Status in Tissue and Plasma Cell-Free DNA Detected by ARMS in Advanced Lung Adenocarcinoma Patients
16:45 - 18:00 | Presenter: Yuping Li | Author(s): Hanyan Xu, Sansan Su, Junru Ye, Chengshui Chen
- Abstract
Loading... -
+
P2.01-67 - The Prognostic Analysis of Lung Cancer Patients with Occult Malignant Pleural Disease at Thoracotomy
16:45 - 18:00 | Presenter: Shaolei Li | Author(s): Panpan Zhang, Shanyuan Zhang, Miao Huang, Yuanyuan Ma, Yue Yang
- Abstract
Loading... -
+
P2.01-68 - Capture-Based Sequencing Depicts Evolution Characteristics of Pulmonary Sarcomatoid Carcinoma
16:45 - 18:00 | Presenter: Xuewen Liu | Author(s): Xinru Chen, Fang Wang, Zhi Xie, Chunwei Xu, Hui Wang, Lianpeng Chang, Xuefeng Xia, Yanfang Guan, Xin Yi, Likun Chen
- Abstract
Loading... -
+
P2.01-69 - EZH2-Mediated Epigenetic Suppression Of GDF15 Predicts a Poor Prognosis and Regulates Cell Proliferation in Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Xiyi Lu | Author(s): Xinyin Liu, Renhua Guo
- Abstract
Loading... -
+
P2.01-70 - Tumor Treating Fields and Radiosurgery for Supra- and/or Infratentorial Brain Metastases (1-10) from NSCLC in the Phase 3 METIS Study
16:45 - 18:00 | Presenter: Uri Weinberg | Author(s): Minesh P Mehta, Vinai Gondi, Manmeet Ahluwalia,, Paul D. Brown
- Abstract
Loading... -
+
P2.01-71 - Clinical Outcome of Induction Chemoradiotherapy Followed by Surgery for the Patients with cN2 Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Akihiro Miura | Author(s): Junichi Soh, Kota Araki, Yuta Takahashi, Eisuke Kurihara, Yusuke Ogoshi, Kazuhiko Shien, Hiromasa Yamamoto, Seiichiro Sugimoto, Masaomi Yamane, Katsuyuki Kiura, Susumu Kanazawa, Shinichi Toyooka
- Abstract
Loading... -
+
P2.01-72 - Bronchial Sleeve vs Pneumonectomy: Complications, Recurrences and Survival
16:45 - 18:00 | Presenter: Marc Boada | Author(s): Mario Montesinos Encalada, David Sanchez, Alejandra Libreros, Angela Guirao, Rudith Guzman, Josep Maria Gimferrer, Laureano Molins
- Abstract
Loading... -
+
P2.01-73 - Automated Image Analysis Tool for Tumor Volume Growth Rate to Guide Precision Cancer Therapy: EGFR-Mutant NSCLC as a Paradigm
16:45 - 18:00 | Presenter: Mizuki Nishino | Author(s): Satoshi Wakai, Tomoyuki Hida, Suzanne Dahlberg, Masahiro Ozaki, Hiroto Hatabu, Hisashi Tachizaki, Bruce E Johnson
- Abstract
Loading... -
+
P2.01-74 - Docetaxel-Related Febrile Neutropenia (FN) And Patient Reported Symptoms/ QOL (PROs) in East Asian (EA) and Non-EA Patients
16:45 - 18:00 | Presenter: Sotaro Enatsu | Author(s): Yukie Omori, Alan J. M. Brnabic, Narayan Rajan, Jin-Yuan Shih, Joo-Hang Kim, Keunchil Park
- Abstract
Loading... -
+
P2.01-75 - Study of Molecular Alterations in Cytological Smears By FISH In Patients with Advanced Non Small Cell Lung Carcinoma (NSCLC).
16:45 - 18:00 | Presenter: Julieta Belén Pandolfi | Author(s): Julia Urbistondo, Maria Jose Labanca, Jose Nicolas Minatta, Mercedes Liliana Dalurzo, Paola Ximena De La Iglesia Niveyro.
- Abstract
Loading... -
+
P2.01-76 - The Impact of Concordance with a Lung Cancer Diagnosis Pathway Guideline on Treatment Access in Patients with Stage IV Lung Cancer
16:45 - 18:00 | Presenter: Luke Jeagal | Author(s): Andrew Pattison, Jonathon Yeung, Andrew Pierre, Laura Donahoe, Marcelo Cypel, Marc De Perrot, Kazuhiro Yasufuku, Gail Elizabeth Darling, Thomas Waddell, Shaf Keshavjee, Kasia Czarnecka-Kujawa
- Abstract
Loading... -
+
P2.01-77 - Interconversion of Two Commonly Used Performance Tools: An Analysis of 5844 Paired Assessments in 1501 Lung Cancer Patients
16:45 - 18:00 | Presenter: Kuruswamy Thurai Prasad | Author(s): Harpreet Kaur, Valliappan Muthu, Ashutosh Nath Aggarwal, Digambar Behera, Navneet Singh
- Abstract
Loading... -
+
P2.01-78 - Validation of InVisionFirst ctDNA NGS Profiling via ddPCR Testing in Patients with Non-Small Cell Lung Cancer (NSCLC)
16:45 - 18:00 | Presenter: Michael A. Pritchett | Author(s): Katherine Baker-Neblett, Katherine Finch Mileham, Vincent Plagnol, Karen Howarth, Tim Forshew, Gregory R. Jones, Clive Morris
- Abstract
Loading... -
+
P2.01-79 - Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Matthew Ramotar | Author(s): Sierra Barnes, Mark K. Doherty, David Shultz
- Abstract
Loading... -
+
P2.01-80 - Performance Status and Resource Utilization in Patients Receiving Palliaitve Care with Stage IV Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Candice Leigh Wilshire | Author(s): Joshua Robert Rayburn, Christopher R Gilbert, Roshanthi K Weerasinghe, Brian E Louie, Ralph W Aye, Alexander S Farivar, Eric Vallieres, Jed A Gorden
- Abstract
Loading... -
+
P2.01-81 - Treatment of Superior Sulcus Tumor: A Twelve-Year Single-Center Experience
16:45 - 18:00 | Presenter: Witold Rzyman | Author(s): Malgorzata Lazar-Poniatowska, Mariusz Lapinski, Marcin Ostrowski, Anna Wrona, Krzysztof Konopa, Jacek Jassem, Rafal Dziadziuszko
- Abstract
Loading... -
+
P2.01-82 - Neutrophil-to-Lymphocyte Ratio Complements the Prognostic Ability of PD-L1 in Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors
16:45 - 18:00 | Presenter: Diana Saravia | Author(s): Sarita Agte, Naoyuki Okabe, Wungki Park, Deukoo Kwon, Raja Mudad, Hiroyuki Suzuki, Young Kwang Chae, Michael Oh, Ashkon Alexander Rahbari, Gilberto de Lima Lopes
- Abstract
Loading... -
+
P2.01-83 - Evaluation of Dynamic Thiol/Disulphide Homeostasis in Advance Non-Small Cell Lung Cancer and Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Mehmet Ali Nahit Sendur | Author(s): Mutlu Hizal, Burak Bilgin, Muhammed Bulent Akinci, Salim Neselioglu, Ozcan Erel, Bulent Yalcin
- Abstract
Loading... -
+
P2.01-84 - Patterns of Central Nervous System Metastases in EGFR Mutated or ALK Rearranged Non Small Cell Lung Cancer Patients
16:45 - 18:00 | Presenter: Mansi Sharma | Author(s): Ullas Batra, Parveen Jain, Vivek Mahawar, Ankush Jajodia
- Abstract
Loading... -
+
P2.01-85 - The Efficacy of the Traditional Chinese Medicine as Maintenance Therapy for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
16:45 - 18:00 | Presenter: Peng Shen | Author(s): Lingyun Wu, Mengye He, Jiabin Chen, Kequn Chai
- Abstract
Loading... -
+
P2.01-86 - Genetic Profiling of Circulating Cell-Free DNA from Cerebrospinal Fluid and Plasma in ALK-Positive Lung Cancer with Brain Metastases
16:45 - 18:00 | Presenter: Liang Shi | Author(s): Jungfang Tang, Mingzhi Li, Li Tong, Hong Tao, Weihua Wu, Hongbo Wu, Lili Guo, Wei Wu, Hongxia Li, Qiyi Meng, Liyan Xu, Yunzhong Zhu, Zhe Liu
- Abstract
Loading... -
+
P2.01-87 - Profiling the Symptom Burden of Patients with Metastatic NSCLC Receiving Either Chemotherapy or Targeted Therapy: Real-World Data
16:45 - 18:00 | Presenter: Qiuling Shi | Author(s): Loretta A Williams, Viralkumar Bharatbhai Vaghani, Meita Hirschmann, Lara Lacerda Landry, Emily Roarty, Jianjun Zhang, Waree Rinsurnogkawong, Jeff Lewis, Charles Cleeland, Jack Lee, Jack A Jack A. Roth, Stephen Swisher, John V Heymach, George R. Simon
- Abstract
Loading... -
+
P2.01-88 - C-Reactive Protein (CRP) as a Predictive Marker for Survival in Patients with Advanced NSCLC Treated with First Line Pembrolizumab Monotherapy
16:45 - 18:00 | Presenter: Yuji Shibata | Author(s): Terufumi Kato, Tadasuke Shimokawaji, Kouzo Yamada
- Abstract
Loading... -
+
P2.01-89 - Synergistic Cytotoxicity Through MAPK/ERK Pathway and ALK Inhibition in Crizotinib Resistant EML4-ALK-Positive Lung Cancer
16:45 - 18:00 | Presenter: Nensi Shrestha | Author(s): Mhairi Nimick, Rhonda Rosengren, John Ashton
- Abstract
Loading... -
+
P2.01-90 - PD-L1 Expression as a Predictive Biomarker in Advanced Non-Small Cell Lung Cancer Patients with or without EGFR Mutation
16:45 - 18:00 | Presenter: Teerada Siripoon | Author(s): Pimpin Incharoen, Narumol Trachu, Dittapol Munthum, Kaettipong Kamprerasart, Thanyanan Reungwetwattana
- Abstract
Loading... -
+
P2.01-91 - Treatment Patterns in Patients with Stage IIIB-IV NSCLC in Clinical Practice: Retrospective Analysis of a UK Trust Database
16:45 - 18:00 | Presenter: Michael Snee | Author(s): Sue Cheeseman, Matthew Thompson, Laure Lacoin, Will Sopwith, Carlos Chaib, Melinda Daumont, John R. Penrod, John O'Donnell, Geoff Hall
- Abstract
Loading... -
+
P2.01-92 - “All-In-One” Window: A New Way of Looking at Chest CT Studies in Thoracic Oncology
16:45 - 18:00 | Presenter: Annemie Snoeckx | Author(s): Pieter Vuylsteke, Bart Broeckx, Ken Carpentier, Robert Corthouts, Elisa Luyckx, Simon Nicolay, Astrid Van Hoyweghen, Maarten J Spinhoven, Annelies Janssens, Jeroen Cant, Jan P Van Meerbeeck, Paul M Parizel
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.01-94 - Diagnostic Patterns of Non-Small Cell Lung Cancer at Princess Margaret Cancer Centre
16:45 - 18:00 | Presenter: Mike Sung | Author(s): Maral Nadjafi, Gilda Santos, Lisa Le, David Hwang, Ming Sound Tsao, Natasha B Leighl
- Abstract
Loading... -
+
P2.01-95 - Assesment the Fitness for Chemotherapy of NSCLC Patients using 6MWT
16:45 - 18:00 | Presenter: Zsuzsanna Szalai | Author(s): Annamária Szipőcs, Katalin Borbála Potyó, Zoltán Szász, Tamás F. Molnár
- Abstract
Loading... -
+
P2.01-96 - Dysgeusia Associated with Nutritional and Quality of Life Parameters in Non-Small Cell Lung Cancer Patients Naïve to Chemotherapy
16:45 - 18:00 | Presenter: Jenny G. Turcott | Author(s): Eva Juarez, Karla Paola Sánchez-Lara, Oscar Arrieta
- Abstract
Loading... -
+
P2.01-97 - Prognostic Factors in Resected Lung Mucinous Adenocarcinoma: Clinical and Pathological Features
16:45 - 18:00 | Presenter: Daisuke Ueda | Author(s): Yasuhiro Tsutani, Masaoki Ito, Yoshihiro Miyata, Morihito Okada
- Abstract
Loading... -
+
P2.01-98 - Single-Isocenter Volumetric-Modulated Arc Radiosurgery for Non-Small-Cell Lung Cancer Patients with Multiple Brain Metastases
16:45 - 18:00 | Presenter: Megumi Uto | Author(s): Tomohiro Katagiri, Keiichi Takehana, Kengo Ogura, Takashi Mizowaki
- Abstract
Loading... -
+
P2.01-99 - Can NGS NSCLC Testing Be Implemented Without in House Expertise? Clinical Utility of the First FDA-Approved Lung Cancer NGS End-To-End Solution
16:45 - 18:00 | Presenter: Anagh Vora | Author(s): Sherrol McDonough, Aparna Aiyer, Anne Marie Velasco Roth, Juscilene Menezes, Jody Schulz, Justine Degrandpre, Erene Mina, Jay H. Shaw
- Abstract
Loading...
-
+
P2.03 - Biology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.03-01 - Prevalence of EGFR Alterations in Chilean Lung Cancer Patients: A Retrospective Study
16:45 - 18:00 | Presenter: Hector Galindo | Author(s): Roger Gejman, Maria L. Bravo, Matias Muñoz, Ignacio N Retamal, Bruno Nervi, Cesar Sanchez, Carolina Ibañez, Jose Peña, Jorge Madrid, Juan Briones, Patricia Perez, Marcelo Garrido, Mauricio P Pinto
- Abstract
Loading... -
+
P2.03-02 - Cell-Free DNA (cfDNA) Testing in Lung Adenocarcinoma (LUAC) Patients: Spanish Lung Liquid Versus Invasive Biopsy Program (SLLIP)
16:45 - 18:00 | Presenter: Ramon Palmero | Author(s): Alvaro Taus, Santiago Viteri, Margarita Majem, Enric Carcereny, Javier Garde-Noguera, Enriqueta Felip, Miguel Sampayo, Lourdes Gomez, Noemi Lopez, Steven R. Olsen, Matthew Jackson, Iris Faull, Daniel Dix, Niki Karachaliou, Rafael Rosell
- Abstract
Loading... -
+
P2.03-03 - Upfront Next Generation Sequencing in NSCLC: A Publicly Funded Perspective
16:45 - 18:00 | Author(s): Tracy Stockley, Ming Sound Tsao, Joshua Morganstein, Suzanne Kamel-Reid, Laura Ranich, Frances A Shepherd, Penelope Bradbury, Geoffrey Liu, David Hwang, Prodipto Pal, Joerg Schwock, Scott Boerner, Adrian Sacher, Jennifer H Law, Natasha B Leighl
- Abstract
Loading... -
+
P2.03-04 - Next Generation Sequencing in Lung Cancer Using the Oncomine Comprehensive Assay: The Canadian Publicly Funded Experience
16:45 - 18:00 | Author(s): Tracy Stockley, Jennifer H Law, Muqdas Shabir, Lisa Le, Ming Sound Tsao, Suzanne Kamel-Reid, Tong Zhang, Maggie Sawczak, David Hwang, Prodipto Pal, Geoffrey Liu, Penelope Bradbury, Frances A Shepherd, Adrian Sacher, Natasha B Leighl
- Abstract
Loading... -
+
P2.03-05 - Biologic Profiling of Brain Metastasis from Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Tomohito Saito | Author(s): Ryoichi Iwata, Masato Maruyama, Yosuke Nakano, Kohei Ofune, Satoshi Matsuda, Masaki Kaibori, Tomohiro Murakawa, Mikio Hayashi
- Abstract
Loading... -
+
P2.03-06 - Serum Syndechan-1 Levels in Patients with Nonsmall Cell Lung Cancer
16:45 - 18:00 | Presenter: Ibrahim Tek | Author(s): Ozkan Yetkin, Gulay Yetkin, Meryem Iraz
- Abstract
Loading... -
+
P2.03-07 - Radiomic Signatures Linked to Genetic Alterations as Detected by Next-Generation Sequencing: A Radiogenomics Analysis of Early-Stage NSCLC
16:45 - 18:00 | Presenter: Sibo Tian | Author(s): Eduard Schreibmann, Subir Goyal, Manali Rupji, Richard J Cassidy, Chase E Escott, Matthew J Ferris, Pretesh R Patel, Walter John Curran, Jr., Kristin A Higgins
- Abstract
Loading... -
+
P2.03-08 - Molecular Spectrum of Patients with MSH2 Mutations in Chinese Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Chunwei Xu | Author(s): Wenxian Wang, Quxia Zhang, Wu Zhuang, Youcai Zhu, Yanping Chen, Meiyu Fang, Gang Chen, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P2.03-09 - The Real World of NTRK Fusion Data in the Chinese Lung Cancer Populations: A Multicenter Study
16:45 - 18:00 | Presenter: Chunwei Xu | Author(s): Wenxian Wang, Youcai Zhu, Yueping Liu, Yu Chen, Quxia Zhang, Hong Wang, Wu Zhuang, Xiaohui Chen, Jinhuo Lai, Meiyu Fang, Ye Tao, Shuguang Xu, Xue Qian, Hongyu Zhao, Shangli Cai, Gang Chen, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P2.03-10 - Gene Mutational Profiling Of Chinese TKI-Sensitizing EGFR Mutations NSCLC Patients Required Resistance to Icotinib Using NGS
16:45 - 18:00 | Presenter: Chunwei Xu | Author(s): Wenxian Wang, Youcai Zhu, Wu Zhuang, Yanping Chen, Gang Chen, Meiyu Fang, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P2.03-11 - PDGFRA Defines a Unique Molecular Subtypes of Chinese Non-Small Cell Lung Cancer Patients
16:45 - 18:00 | Presenter: Chunwei Xu | Author(s): Wenxian Wang, Quxia Zhang, Wu Zhuang, Youcai Zhu, Yanping Chen, Meiyu Fang, Gang Chen, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P2.03-12 - EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer
16:45 - 18:00 | Presenter: Shun Lu | Author(s): Yongfeng Yu, Ziming Li, Yang W. Shao, Xue Wu, Yan Ding, Hairong Bao, Hong Jian
- Abstract
Loading... -
+
P2.03-13 - SWATH MS Analysis of Serine Hydrolase Activity in Human Lung Adenocarcinoma for Biomarker Discovery
16:45 - 18:00 | Presenter: Sven Hillinger | Author(s): Tatjana Sajic, Stephan Arni, Walter Weder, Rudi Aebersold
- Abstract
Loading... -
+
P2.03-14 - PKCι-PAK1 Pathway Modulates Sensitivity to Therapy in EGFR, KRAS Mutant and Squamous Cell Non-Small Cell Lung Cancer (NSCLC)
16:45 - 18:00 | Presenter: Masaoki Ito | Author(s): Carles Codony-Servat, Jordi Codony-Servat, Ilaria Attili, Jordi Berenguer, Jillian Wilhelmina Paulina Bracht, Nuno Gil, Morihito Okada, Niki Karachaliou, Peng Cao, Rafael Rosell
- Abstract
Loading... -
+
P2.03-15 - Integrin-Linked Kinase (ILK), Protein Tyrosine Phosphatase SHP2 and B lymphoma Mo-MLV Insertion Region 1 Homolog (Bmi-1) in EGFR-Mutant NSCLC
16:45 - 18:00 | Presenter: Niki Karachaliou | Author(s): Imane Chaib, Jillian Wilhelmina Paulina Bracht, Martyna Filipska, Ana Drozdowskyj, Andrés F. Cardona, Alain Vergnenegre, José Miguel Sánchez-Torres, Mariano Provencio, Filippo De Marinis, Enric Carcereny, Noemi Reguart, Rosario García Campelo, Mariacarmela Santarpia, Santiago Viteri, Trever G Bivona, Rafael Rosell
- Abstract
Loading... -
+
P2.03-16 - TGF-β Induced EMT and Stemness Characteristics are Associated with Epigenetic Regulation in Lung Cancer
16:45 - 18:00 | Presenter: Seung Joon Kim | Author(s): Nahyeon Kang, Bit Na Kim, Chan Kwon Park, Young Kyoon Kim
- Abstract
Loading... -
+
P2.03-17 - EGFR T790M Mutation may not be Generated through Selection by EGFR-TKI from Randomly Occurring Mutations in Vitro Using ENU
16:45 - 18:00 | Presenter: Yoshihisa Kobayashi | Author(s): Tetsuya Mitsudomi
- Abstract
Loading... -
+
P2.03-18 - X-Inactivation Specific Transcript (XIST)-Mediated miRNA Sequestration In NSCLC
16:45 - 18:00 | Presenter: Erin A Marshall | Author(s): Greg L. Stewart, Adam P Sage, Wan Lam, Carolyn J Brown
- Abstract
Loading... -
+
P2.03-19 - RET-Mediated Activation of Ezrin is Associated with Cell Motility and Survival in a Subset of Lung Adenocarcinomas
16:45 - 18:00 | Presenter: Serisha Moodley | Author(s): Mathieu Crupi, Jenny Zhao, Brandy Hyndman, Taran Gujral, Lois M Mulligan
- Abstract
Loading... -
+
P2.03-20 - Factor XIIIA-Expressing Inflammatory Monocytes Promote Lung Squamous Cancer through Fibrin Cross-Linking
16:45 - 18:00 | Presenter: Chad Victor Pecot
- Abstract
Loading... -
+
P2.03-21 - Mechanistic Investigation of DRD1 in Lung Cancer
16:45 - 18:00 | Presenter: Leila Toulabi | Author(s): Christopher Grant, Adriana Zingone, Khadijah A Mitchell
- Abstract
Loading... -
+
P2.03-22 - OCT4&SOX2 Specific CTLs Plus PD-1 Inhibitor Had Synergistic Effect on Killing CSC And Treating Drug-Resistant Lung Cancer Mice
16:45 - 18:00 | Presenter: Fang Hu | Author(s): Xueyan Zhang, Xiaoxuan Zheng, Bo Zhang, Huimin Wang, Guangyu Tao, Jianlin Xu, Yanwei Zhang, Baohui Han
- Abstract
Loading... -
+
P2.03-23 - MicroRNA-30e Inhibits Cell Proliferation and Invasion in Non-Small Cell Lung Cancer via Directly Targeting SOX9
16:45 - 18:00 | Presenter: Lei Zhao | Author(s): Zhao Shilei, Chundong Gu, Yixiang Zhang, Zhe Sun
- Abstract
Loading... -
+
P2.03-24 - CD90 Enhances Metastasis by Epithelial-Mesenchymal Transdifferentiation in Lung Adenocacinoma
16:45 - 18:00 | Presenter: Xiangdong Zhou | Author(s): Liu Pan
- Abstract
Loading... -
+
P2.03-25 - Loss of Expression Rather Than Cytoplasmic Mislocalization of RUNX3 Predicts Worse Outcome in Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Xiaohui Chen | Author(s): Yujie Deng, Yi Shi, Weifeng Zhu, Kunshou Zhu, Xiongwei Zheng, Gen Lin
- Abstract
Loading... -
+
P2.03-26 - A Prospective Cohort Study of TMB and Determinants of ctDNA Detection by Comprehensive Genomic Profiling in Stage I Lung Adenocarcinomas
16:45 - 18:00 | Presenter: Kezhong Chen | Author(s): Heng Zhao, Jing Bai, Fan Yang, Lianpeng Chang, Yanfang Guan, Xin Yi, Lin Feng, Shujun Cheng, Jun Wang
- Abstract
Loading... -
+
P2.03-27 - Polymorphisms in Folate Metabolism Related Genes Affect the Survival Outcomes of Early-Stage Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Sun ha Choi | Author(s): Sook Kyung Do, Jin Eun Choi, Seung soo Yoo, Shin Yup Lee, Jae Young Park
- Abstract
Loading... -
+
P2.03-28 - Whole Exome Sequencing to Discover Lung Tumor Predisposition in Women with Previous Breast Cancer
16:45 - 18:00 | Presenter: Carlo Genova | Author(s): Francesco Grossi, Silvia Bonfiglio, Davide Cittaro, Irene Vanni, Marco Mora, Simona Boccardo, Maria Giovanna Dal Bello, Erika Rijavec, Claudio Sini, Angela Alama, Giulia Barletta, Federica Biello, Giovanni Rossi, Marco Tagliamento, Giovanni Burrafato, Alberto Ballestrero, Simona Coco
- Abstract
Loading... -
+
P2.03-29 - Prognostic Significance of Phosphorylated Fyn in Patients with Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Shigeto Nishikawa | Author(s): Toshi Menju, Terumasa Sowa, Takao Nakanishi, Koji Takahashi, Ryo Miyata, Hiroyuki Ishikawa, Misa Noguchi, Yojiro Yutaka, Masatsugu Hamaji, Daisuke Nakajima, Akihiro Ohsumi, Toshihiko Sato, Toyofumi Fengshi Chen Yoshikawa, Makoto Sonobe, Hiroshi Date
- Abstract
Loading... -
+
P2.03-30 - Proteins Involved in Necroptosis and DNA Damage Repair and Survival of Stage I Non-Small-Cell Lung Cancer Patients
16:45 - 18:00 | Presenter: Jeong-Seon Ryu | Author(s): Min-Seong Jo, Jong-Hyeon Nam, Jun Hyeok Lim, Hae-Seong Nam, Hyeon Jung Kim
- Abstract
Loading... -
+
P2.03-31 - LncRNA RGMB-AS1 Affects Lung Adenocarcinoma Prognosis by Regulating Microtube Associated Genes: A Genome-Wide Analysis in Silicon
16:45 - 18:00 | Presenter: Xiaoshun Shi | Author(s): Yuanyuan Wang, Di Lu, Xiguang Liu, Siyang Feng, Xiaoying Dong, Kaican Cai
- Abstract
Loading... -
+
P2.03-32 - Genome-Wide Analysis of m6A-Modified RNA Binding Proteins Associated with Lung Cancer Survival
16:45 - 18:00 | Presenter: Xiaoshun Shi | Author(s): Yuanyuan Wang, Di Lu, Xiguang Liu, Xiaoying Dong, Siyang Feng, Kaican Cai
- Abstract
Loading... -
+
P2.03-33 - Anti-Aging Gene, Klotho is a Predictive Factor of Pemetrexed for Lung Cancer Treatment
16:45 - 18:00 | Presenter: Kyoshiro Takegahara | Author(s): Jitsuo Usuda
- Abstract
Loading... -
+
P2.03-34 - The Relationship Between Treatment Response and Serum EGFR Level in Nonsmall Cell Lung Cancer
16:45 - 18:00 | Presenter: Ibrahim Tek | Author(s): Hakan Akbulut, Gungor Utkan, Ahmet Demirkazik, Filiz Cay Senler, Fikri İcli
- Abstract
Loading... -
+
P2.03-35 - Non-Small-Cell Lung Cancer with SMO Gene Variants of Uncertain Significance Share Distinct Molecular Features
16:45 - 18:00 | Presenter: Chunwei Xu | Author(s): Wenxian Wang, Quxia Zhang, Wu Zhuang, Youcai Zhu, Yanping Chen, Gang Chen, Meiyu Fang, Tang Feng Lv, Yong Song
- Abstract
Loading... -
+
P2.03-36 - DNA Methylation: A More Sensitive Marker for Treatment Monitoring?
16:45 - 18:00 | Presenter: Yu Chen | Author(s): Shu Xia, Shannon Chuai, Le Huang, Wanglong Deng, Han Han Zhang, Yu Zhang, Fei Xu, Xiaoli Ren, Yuan Chen
- Abstract
Loading... -
+
P2.03-37 - The Efficiency of Octamer-4 Specific Cytotoxic T Cells Induce By CD40-B Cells in Killing Lung Cancer Stem-Like Cells
16:45 - 18:00 | Presenter: Fang Hu | Author(s): Xueyan Zhang, Jianlin Xu, Huimin Wang, Xiaoxuan Zheng, Yanwei Zhang, Yuqing Lou, Baohui Han
- Abstract
Loading...
-
+
P2.04 - Immunooncology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.04-01 - Associations Histological Subtype of Lung Adenocarcinoma and Programmed Death Ligand 1 (PD-L1) Expression in Tumor Cells.
16:45 - 18:00 | Presenter: Luis Antonio Cabrera-Miranda | Author(s): Graciela Cruz-Rico, Xitlally Popa Navarro, Alejandro Avilés-Salas, Karen Yocelin Flores-Vélez, Andrés F. Cardona, Laura-Alejandra Ramírez-Tirado, Edgar Vergara, Feliciano Barron, Oscar Arrieta
- Abstract
Loading... -
+
P2.04-02 - Predictive Value of Circulating Tumor Cells and Circulating Free DNA in NSCLC Patients Treated with Nivolumab
16:45 - 18:00 | Presenter: Carlo Genova | Author(s): Giovanni Rossi, Marco Tagliamento, Angela Alama, Simona Coco, Erika Rijavec, Giulia Barletta, Federica Biello, Irene Vanni, Simona Boccardo, Maria Giovanna Dal Bello, Rosa Alessandra, Vincenzo Fontana, Francesco Grossi
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.04-04 - Expression of Intratumoral Programmed Cell Death-Ligand 1 (PD-L1) and Intratumoral CD4+T Cell, CD8+T Cell and FOXP3+T Cell in Lung Cancer
16:45 - 18:00 | Presenter: Yasuto Jin | Author(s): Hiroyuki Shimada, Shuta Yamauchi, Naohiko Inase, Osamu Matsubara
- Abstract
Loading... -
+
P2.04-05 - Correlation Between PD-L1 Gene Promoter Polymorphisms and Expression of PD-L1 mRNA and Protein in NSCLC Patients.
16:45 - 18:00 | Presenter: Pawel Krawczyk | Author(s): Tomasz Kucharczyk, Anna Grenda, Marcin Nicoś, Bożena Jarosz, Justyna Szumiło, Katarzyna Reszka, Tomasz Trojanowski, Janusz Milanowski
- Abstract
Loading... -
+
P2.04-06 - Increased Plasma Cell % and Decreased B-Cells in Tumor Immune Infiltrates Are Associated with Worse Prognosis in Lung Adenocarcinomas
16:45 - 18:00 | Presenter: Hee Eun Lee | Author(s): Lei Luo, Trynda Kroneman, Marie Passow, Kristina Del Rosario, Michael Christensen, Mary Francis, John O’shaughnessy, Anthony Blahnik, Ping Yang, Eunhee Yi
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.04-08 - Platinum-Based Chemotherapy is Associated with Altered PD-L1 Expression in Lung Cancer
16:45 - 18:00 | Presenter: Judit Moldvay | Author(s): Lívia Rojkó, Vanda Téglási, Katalin Fábián, Orsolya Pipek, Attila Vágvölgyi, László Agócs, János Fillinger, Zita Kajdácsi, József Tímár, Balázs Döme, Zoltán Szállási, Lilla Reiniger
- Abstract
Loading... -
+
P2.04-09 - Driver Mutations are Associated with Distinct Patterns of Response to Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Marcelo Vailati Negrao | Author(s): Alexandre Reuben, Jacqulyne Ponville Robichaux, Xiuning Le, Monique Nilsson, Yasir Y Elamin, Chang-Jiun Wu, Jianhua Zhang, Lara Lacerda Landry, Emily Roarty, Waree Rinsurongkawong, Stephen Swisher, George R. Simon, P. Andrew Futreal, Bonnie S Glisson, Jianjun Zhang, John V Heymach
- Abstract
Loading... -
+
P2.04-10 - Early Monitoring of Blood Biomarkers to Predict Nivolumab Efficacy in NSCLC Patients
16:45 - 18:00 | Presenter: Francesco Passiglia | Author(s): Antonio Galvano, Hector Josè Soto Parra, Sergio Rizzo, Angela Listì, Salvatore Mazzarisi, Alessandro Perez, Marta Castiglia, Valentina Calò, Viviana Bazan, Antonio Russo
- Abstract
Loading... -
+
P2.04-11 - An IL-8/IFN-gammma/NLR Plasma Score to Predict Nivolumab Efficacy in Patients with NSCLC
16:45 - 18:00 | Presenter: Francesco Passiglia | Author(s): Antonio Russo, Simona Ferro, Luca Lalli, Agata Cova, Hector Josè Soto Parra, Licia Rivoltini, Veronica Huber
- Abstract
Loading... -
+
P2.04-12 - A Genomic Signature [JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2] Predicts Baseline Resistance to Nivolumab in Advanced NSCLC.
16:45 - 18:00 | Presenter: Sara Pilotto | Author(s): Giulia Grizzi, Isabella Sperduti, Michele Simbolo, Caterina Vicentini, Anna Caliò, Mario Caccese, Andrea Mafficini, Luisa Carbognin, Vincenzo Corbo, Anastasios Gkountakos, Antonio Santo, Maurizio Infante, Matteo Brunelli, Aldo Scarpa, Giampaolo Tortora, Emilio Bria
- Abstract
Loading... -
+
P2.04-13 - The Immune Checkpoint, HVEM Contribute to Immune Escape in Non Small Cell Lung Cancer of Lacking PDL1 Expression
16:45 - 18:00 | Presenter: Shengxiang Ren | Author(s): Hui Yu, Christopher J. Rivard, Kenichi Suda, Charles Caldwell Jr, Leslie Rozeboom, Terry L. Ng, Gareth Rivalland, Paul Mitchell, Caicun Zhou, Fred R. Hirsch
- Abstract
Loading... -
+
P2.04-14 - Tumor Mutational Burden Assessed by a Targeted NGS Assay Predicts Benefit from Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Sacha I Rothschild | Author(s): Philip Jermann, Spasenija Savic, Kirsten Mertz, Alfred Zippelius, Luca Quagliata, Lukas Bubendorf
- Abstract
Loading... -
+
P2.04-15 - Heterogeneity and Correlation Between Immune Markers in Lung Cancers: Analysis of Treatment-Naïve Lesions
16:45 - 18:00 | Presenter: Kenichi Suda | Author(s): Jihye Kim, Isao Murakami, Leslie Rozeboom, Christopher J. Rivard, Tetsuya Mitsudomi, Aik-Choon Tan, Fred R. Hirsch
- Abstract
Loading... -
+
P2.04-16 - Correlation Between Programmed Death Ligand 1(PD-L1) Expression and Solid Component on HRCT in Stage I Lung Cancer Patients
16:45 - 18:00 | Presenter: Ryosuke Tsugitomi | Author(s): Naoki Nishimura, Hiroaki Kanemra, Ryosuke Imai, Nobuyuki Yoshiyasu, Kohei Okafuji, Atsushi Kitamura, Yutaka Tomishima, Fumitsugu Kojima, Torahiko Jinta, Koyu Suzuki, Toru Bando, Tomohide Tamura
- Abstract
Loading... -
+
P2.04-17 - Pre-Therapy Radiomic Features Can Distinguish Hyperprogression from Other Response Patterns to PD1/PD-L1 Inhibitors in NSCLC
16:45 - 18:00 | Presenter: Pranjal Vaidya | Author(s): Pradnya Dinkar Patil, Kaustav Bera, Mohammadhadi Khorrami, Prantesh Jain, Anant Madabhushi, Vamsidhar Velcheti
- Abstract
Loading... -
+
P2.04-18 - The Association Between IDO Activity and Clinical Prognosis in Patients with Non-Small Cell Lung Cancer After Radiotherapy
16:45 - 18:00 | Presenter: Yaping Xu | Author(s): Yaoyao Zhu, Chenxue Jiang, He Wu, Qinghua Xu, Jianguo Feng
- Abstract
Loading... -
+
P2.04-19 - Correlation of Clinicopathological Characteristics with Tumor Mutation Burden in Chinese Patients with NSCLC
16:45 - 18:00 | Presenter: Shun Lu | Author(s): Yongfeng Yu, Guan Wang, Jinwang Wei, Qiang Xu
- Abstract
Loading... -
+
P2.04-20 - Immunologic Characterization of Fibrinous Pericarditis as an Immune Checkpoint Blockade Toxicity in NSCLC
16:45 - 18:00 | Presenter: Mehmet Altan | Author(s): Maria I. Toki, Daniel Carvajal-Hausdorf, Scott N. Gettinger, Roy S. Herbst, David L. Rimm
- Abstract
Loading... -
+
P2.04-21 - Real World Experience of Immune Checkpoint Inhibitors In NSCLC: Our First 10 Months Experience at Leeds Cancer Centre, UK
16:45 - 18:00 | Presenter: Kathryn Ellenger | Author(s): Michael Flatley, Katie Spencer, Katy Louise Clarke, Kevin Franks, Pooja Jain
- Abstract
Loading... -
+
P2.04-22 - Dendritic Cell Based Immunotherapy in Stage IIB-IIIA Non-Small Cell Lung Cancer Patients: 10-Years Experience.
16:45 - 18:00 | Presenter: Natalia Khranovska | Author(s): Oksana Skachkova, Oleksandr Gorbach, Volodimir Sovenko, Andriy Ganul, Mariia Inomistova, Valeriy Orel
- Abstract
Loading... -
+
P2.04-23 - Immune-Related Adverse Events: The Growing Pains of Immunooncology
16:45 - 18:00 | Presenter: Meghan J Mooradian | Author(s): Ibiayi Dagogo-Jack, Justin F Gainor, Kerry Reynolds
- Abstract
Loading... -
+
P2.04-24 - Nivolumab in the "Real World": Are the Results of Clinical Trials Reproducible?
16:45 - 18:00 | Presenter: Inmaculada Ramos García | Author(s): Amparo Sanchez Gastaldo, Isidoro Barneto, Pable Ayala, Miguel Berciano, Reyes Bernabé, Marta Robles, Ricardo Collado, Miriam Alonso, Teresa García, Manuel Cobo Dols, Jose Manuel Trigo
- Abstract
Loading... -
+
P2.04-25 - Randomized Clinical Trial Comparing Immunotherapy Plus SABR (I-SABR) Versus SABR Alone for Early Stage NSCLC
16:45 - 18:00 | Presenter: Joe Y Chang | Author(s): Lei Feng, Steven H Lin, James William Welsh, Mara B Antonoff, Daniel Gomez, John V Heymach
- Abstract
Loading... -
+
P2.04-26 - Interim Results from a Phase I/II Trial of Nivolumab in Combination with CIMAvax-EGF as Second-Line Therapy in Advanced NSCLC
16:45 - 18:00 | Presenter: Grace K Dy | Author(s): Askia Dozier, Mary Reid, Kelvin Lee, Austin Miller, Paul Wallace, Igor Puzanov, Mateusz Opyrchal, Marc Ernstoff, Candace Johnson, Zaima Mazorra, Danay Saavedra, Kalet Leon, Agustin Lage, Tania Crombet
- Abstract
Loading... -
+
P2.04-27 - Ph II Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) in Combination with Pembrolizumab in Patients with Advanced NSCLC
16:45 - 18:00 | Presenter: James Lorens | Author(s): Carlos Arce-Lara, Edurne Arriola, Paal Brunsvig, Enric Carcereny, Manuel Domine, Konstantin Dragnev, Enriqueta Felip, Rosario García Campelo, Matthew G Krebs, Luis Paz-Ares, Santiago Ponce Aix, James Spicer, Jose Manuel Trigo, Nuria Vinolas Segarra, Robert Holt, David Micklem, Anthony Brown, Michael Chisamore
- Abstract
Loading... -
+
P2.04-28 - Use of Immune Checkpoint Inhibitors (ICIs) in Patients with Refractory Non-Small Cell Lung Cancer (NSCLC) and Poor Performance Status (PS)
16:45 - 18:00 | Presenter: Jonathan R Thompson | Author(s): Carlos Arce-Lara, Smitha P. Menon
- Abstract
Loading... -
+
P2.04-29 - Preliminary Results With Tislelizumab in Chinese Patients With Non-Small Cell Lung Cancer (NSCLC)
16:45 - 18:00 | Presenter: Yi-Long Wu | Author(s): Jun Zhao, Qingyuan Zhang, Hongming Pan, Jie Wang, Yuxian Bai, Jian Li, Zuobai Wang, Chenlu Wei, Xin Li, Qing Zhou
- Abstract
Loading... -
+
P2.04-30 - PD-1/PD-L1 Inhibition Might be an Option for the Treatment of Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma
16:45 - 18:00 | Presenter: Xu-Chao Zhang | Author(s): Kai Yin, Zhi Xie, Xue-Ning Yang, Wei-Bang Guo, Yu Chen, Wen-Qing Yan, Jin-Ji Yang, Qing Zhou, Wen-Zhao Zhong, Yi-Long Wu
- Abstract
Loading...